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Zusammenfassung 
 
Zusammenfassung 
 
 
Das kleine ubiquitin-ähnliche Protein SUMO kann kovalent mit Substratproteinen 
verknüpft werden. Neben der Ubiquitylierung ist dies der am besten untersuchte Fall 
einer posttranslationalen Veränderung von Proteinen durch Anheften sogenannter 
Modifikatorproteine. SUMO besteht aus ca. 100 Aminosäuren und wird in Eukaryonten, 
z. B. in Hefe, Menschen und Pflanzen, an Substrate angeheftet. Dazu dienen spezifische 
Enzyme, nämlich SUMO aktivierendes Enzym SAE, SUMO konjugierendes Enzym SCE 
und SUMO Ligasen. Diese Enzyme sind homolog zur Enzymkaskade E1, E2 und E3, 
welche die Konjugation von Ubiquitin katalysiert. SUMO stellt sich als vielseitig 
verwendetes Modifikatorprotein heraus, das eine große Zahl an Substraten in 
verschiedenen Stoffwechsel und Signaltransduktionswegen aufweist, und die 
Konsequenzen der Modifikation scheinen so vielfältig zu sein wie die Substratproteine 
selbst. Arabidopsis thaliana hat acht Gene mit Ähnlichkeit zu SUMO aus Pilzen oder 
Tieren. Phylogenetisch können sie in fünf Gruppen eingeteilt werden: SUMO1/2, 
SUMO3, SUMO5, SUMO4/6, und SUMO7/8. Vier der Arabidopsis SUMO Gene, 
SUMO1, 2, 3 und 5, werden stark exprimiert und in vivo zur Bildung von Konjugaten 
herangezogen. Um SUMO Substrate in Pflanzen zu identifizieren und zu charakterisieren, 
wurden SUMO Gene aller Gruppen mit Epitop-Tag versehen und in der Pflanze 
Arabidopsis thaliana exprimiert. Nach Expression von SUMO1 mit Epitop-Tag und 
biochemischer Anreicherung wurde eine Reihe hochmolekularer Konjugate im 
Coomassie-gefärbten Gel erhalten. MALDI-TOF Analyse erlaubte die Identifizierung 
von 25 neuen potentiellen Substraten der Sumoylierung in Arabidopsis. Einige dieser 
Kandidatenproteine enthalten ein sogenanntes Konsensus-Sumoylierungs-Motif. Es 
konnte gezeigt werden, dass eines dieser Proteine, NAF, auch in vitro ein Substrat der 
Sumoylierung ist.  
 Alle SUMO Proteine werden zunächst als inaktive Vorstufen hergestellt. Die 
Reifung erfolgt durch proteolytische Spaltung am Carboxyl-Terminus, an dem ein Di-
Glycin Motif freigelegt wird. Um zu testen, ob diese beiden terminalen Aminosäuren für 
die Konjugation essentiell sind, wurden SUMO Varianten hergestellt und getestet, die  
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Alanin-Glycin, Glycin-Alanin oder Alanin-Alanin an deren Stelle aufweisen. Anders als 
erwartet konnten in Arabidopsis Konjugate mit allen Varianten nachgewiesen werden, 
was die hohe Flexibilität des pflanzlichen SUMO Konjugationssystems belegt. Es konnte 
auch die Anhäufung von Konjugaten nachgewiesen werden, welche nach Expression von 
SUMO 1 mit einem Glutamin zu Alanin Austausch in Position 93 in Arabidopsis 
entstanden. Weiters wurden Pflanzen untersucht, deren Fähigkeit zur Bildung von SUMO 
Konjugaten durch Expression eines veränderten SUMO konjugierenden Enzyms 
beeinträchtigt war. Im veränderten Enzym ist das Cystein des aktiven Zentrums durch 
Serin ersetzt. Phänotypische Charakterisierung der exprimierenden Pflanzen zeigte 
Kleinwüchsigkeit und frühzeitige Blühinduktion im Lang - sowie im Kurztag. Analyse 
mittels Immunoblot ergab, dass die veränderten Pflanzen eine geringere Konzentration an 
freiem SUMO aufweisen. Insgesamt zeigen die Ergebnisse, dass ähnlich wie in anderen 
Eukaryonten viele Pflanzenproteine durch SUMO modifiziert werden können und dass 
dieser Prozess wichtig ist für Entwicklung und Zelluläre Funktionen von Arabidopsis 
thaliana. 
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1.    INTRODUCTION 
 
1.1   Polypeptides as protein modifiers 
 
All organisms use a variety of chemical modifiers for the post-translational control of 
proteins that effect development, growth and homoeostasis. In these cases, specific amino 
acid residues of target proteins are modified by molecules such as methanol, acetate, fatty 
acids, sugars, nucleosides and phosphate. In addition to these molecules, eukaryotes also 
employ polypeptides as protein modifiers. Ubiquitin (Ub) was one such polypeptide that 
was first described to covalently attach to other proteins after their synthesis has been 
completed. This concept of covalent attachment of one polypeptide to another was first 
realized ~ 25 years ago with the noble prize winning work of Hershko, Ciechanover, Rose 
and coworkers (Hershko and Ciechanover, 1998). Conjugation of ubiquitin (termed 
ubiquitination) has a well established role in earmarking proteins for degradation by the 
26S proteosome. During the past few years, a panoply of proteins have been discovered 
in eukaryotes that have sequence similarity to ubiquitin. The ubiquitin like proteins fall 
into two separate classes (Jentsch and Pyrowolakis, 2000). Proteins of the first class 
termed as ‘ubiquitin-like modifiers’ (UBLs) function in a manner analogous to that of 
ubiquitin. Examples include SUMO (small ubiquitin-like modifier), Rub1 (also named 
Nedd8), Apg8 and Apg12. Proteins of the second class include RAD23, DSK2 and parkin. 
They bear domains that are related in sequence to ubiquitin (otherwise unrelated to each 
other) and are designated ‘ubiquitin domain proteins’ (UDPs). In contrast to UBLs, these 
proteins are not conjugated to other proteins (Hochstrasser et al. 2000). In the UBLs class 
of proteins, some polypeptides are highly similar to each other in amino acid sequence 
(Ub and Rub1), whereas others share little homology (Ub and Apg 8). Despite their 
sequence diversity, structure determinations indicate that most of these polypeptides 
adopt a similar three-dimensional shape (Fig. 1 e.g Ub and SUMO). 
 
 1.2  Discovery of SUMO modification 
 
SUMO was first discovered in animals during studies on nuclear import in mammalian  
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cells as a covalent modifier of RanGAP1, a protein associated with the nuclear import 
complex. On amino acid sequencing, RanGAP1 was discovered to have two N-termini, 
but only one C-terminus, indicating that the protein contained a second polypeptide 
attached through a isopeptide bond (Matunis et al. 1996). The tagged polypeptide was 
termed SUMO (small ubiquitin-like modifier) based on its weak similarity to ubiquitin 
(Mahajan et al. 1997). This discovery was also facilitated by the fact that RanGAP1 is 
quantitatively and constitutively modified with SUMO. This modification targets the 
cytosolic RanGAP1 to the nuclear pore complex where it plays a role in nuclear import 
by activating the GTPase activity of cytosol\nuclear shuttling factor Ran (Mahajan et al. 
1998). SUMO was also identified independently in a number of other studies subsequently 
coining alternate names for the protein as Sentrin, Smt 3, UBL1, GMP or PIC1 (Okura et 
al. 1996; Mannen et al. 1996; Shen et al. 1996; Boddy et al. 1996). 
   
1.3 SUMO structure and isoforms 
 
SUMOs share only ~18 % sequence identity with ubiquitin, although structure analysis 
by nuclear magnetic resonance (NMR; Bayer et al.1998) revealed that both share a 
common three dimensional structure that is characterized by a tightly packed globular 
fold with the β-sheets wrapped around one α-helix. The three-dimensional folds of 
SUMO and ubiquitin can be superimposed (Fig. 1). The Gly Gly motif at the C terminus 
of both the proteins, which is the site of attachment to target proteins, is also positioned 
alike.  However, the surface charge topology of SUMO is quite different from ubiquitin, 
with distinct positive and negative regions (Müller et al. 2001). SUMO proteins contain 
an unstructured short amino-terminal extension of up to 22 residues not present in 
ubiquitin, which provides an additional interface for protein-protein interactions (Seeler 
and Dejean, 2003). This extension varies among different SUMO proteins from 11 to 35 
amino acids and is well conserved within, but not between different SUMO families. 
Interestingly, SUMO proteins do not have the lysine residue corresponding to Lys-48 in 
the ubiquitin molecule that is required for the formation of poly ubiquitin chains, 
implying that SUMO does not make the same type of multi chain as ubiquitin (Bayer et 
al. 1998). 
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SUMOs are ca. 15 kDa proteins present in all eukaryotic kingdoms and highly conserved 
from yeast to humans. The yeast and invertebrates studied up to date contain only a single 
SUMO gene termed as SMT3, originally discovered as a suppressor of mutants in the 
centromeric protein MIF2 (Meluh and Koshland, 1995). While the SUMO encoding 
SMT3 is essential for the viability in budding yeast Saccharomyces cerevisiae, (Johnson 
and Blobel, 1997) fission yeast Schizosaccharomyces pombe lacking the SUMO gene 
PMT3 are barely viable and have severe defects in the genome maintenance (Tanaka et al. 
1999). The mammalian SUMO family members consist of SUMO1, SUMO2 and 
SUMO3 (Kamitani et al. 1998). SUMO1 shares 48% identity with SUMO2 and 46% 
identity with SUMO3. SUMO2 and SUMO3 share 95% identity, and can be grouped into 
a subfamily distinct from SUMO1. All three members have distinct N-terminal amino 
acid sequences and C-terminal extensions. The recently identified fourth isoform, 
SUMO4, is encoded by a sequence that lies within an intron of the human TAB2 gene 
(Bohren et al. 2004). The divergence of the functions of these various isoforms is just 
beginning to emerge. Like SUMO1, other members of this family can also be conjugated 
to target proteins. Recent studies of Saitoh and Hinchey (2000) have shown the functional 
heterogeneity of SUMO family members. Using an antibody which interacts with 
SUMO2 and SUMO3, but not with SUMO1, they demonstrated that SUMO2 and SUMO3 
 
Fig. 1 Ribbon diagrams highlight the 
similarity of the three-dimensional 
structures of ubiquitin and human 
SUMO1 (taken from Dohmen 2004).
Both proteins have a tightly packed 
ββαββαβ fold. Notably SUMO has a N-
terminal extension not found in ubiquitin. 
X-ray crystallography was used for 
determining the structure of ubiquitin 
(Vijay-Kumar et al. 1987); the structure 
of SUMO was determined in solution by 
NMR technique (Bayer et al. 1998).
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are conjugated poorly to RanGAP1, a major SUMO1 target protein. However, conjugation 
of SUMO 2\3 can be strongly induced in response to various stress conditions such as 
high temperature. (Saitoh et al. 2000). Another difference between SUMO1 and 
SUMO2\3\4 is that while SUMO2, SUMO3 and SUMO4 contain a SUMO attachment 
consensus sequence (ψKXE\D, where ψ is a hydrophobic aliphatic residue, X is any 
residue and K, E and D correspond to the standard one letter symbols for amino acids; K 
is the lysine where  SUMO attaches) in their N-terminal extension, such a site is absent 
from SUMO1. Consistent with this observation, in contrast to SUMO1, SUMO2\3 as 
well as SUMO4 have been shown to form SUMO chains in vivo and in vitro (Tatham et 
al. 2001). 
Plants contain even more SUMO genes. The genome of the model plant Arabidopsis 
thaliana has nine genes that show similarity to animal and fungal SUMO proteins. (Table 
1; Kurepa et al. 2003)  One of them, namely SUMO9, is a pseudogene and does not 
encode a complete SUMO protein. Phylogenetic analysis clustered the eight full-length 
Arabidopsis SUMO proteins into five subfamilies: SUMO1\2, SUMO3, SUMO5, 
SUMO4\6 and SUMO7\8 (Fig. 2). The SUMO gene family is potentially derived from 
genome rearrangements. For instance, SUMO2 and SUMO3, as well as SUMO4 and 
SUMO6 are closely linked and are listed as examples of tandem duplications. The same 
probably holds true for SUMO7 and SUMO8 (Novatchkova et al. 2004). Sequence 
comparison shows that SUMO1\SUMO2, SUMO4\SUMO6 and SUMO7\SUMO8, 
respectively, are very similar to each other (Fig. 3). SUMO5 is sequentially most distinct 
for all other Arabidopsis SUMOs. ESTs (expression sequence tags) exist for SUMO1, 
SUMO2, SUMO3 and SUMO5, providing evidence for in vivo expression. The 
expression levels of SUMO4, SUMO6, SUMO7 and SUMO8, if they do not represent 
pseudogenes, is very low. Forced expression of an intron-containing SUMO7 construct 
allowed detection of mRNA (Budhiraja, R. and Bachmair A., unpublished). cDNA isolation 
indicated the formation of two splice variants, SUMO7 and SUMO7v. The latter has a 
three amino acid insertion (Glu-Leu-Gln) at the position of the second intron (see Fig. 3). 
Forced expression of SUMO6 confirms the intron-exton structure as predicted by 
computer algorithms (Novatchkova et al. 2004). 
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Fig. 2 Phylogentic tree of the Arabidopsis SUMO family. SUMO1\2, SUMO3 and 
SUMO5 are highly expressed. SUMO4, SUMO6, SUMO7, SUMO8 have low expression 
levels. 
 
 
 
As with yeast and animal SUMOs, Arabidopsis SUMO1-8 bear additional C-terminal 
residues beyond the glycine necessary for conjugation. Presumably, these residues are 
removed post-translationally by SUMO proteases to generate the mature active tags of 
96-100 amino acids. Whereas most mature Arabidopsis SUMOs, like ubiquitin, are 
predicted to terminate in a Gly Gly motif, three (SUMO4, 6 and 7) are predicted to end in 
a single glycine. However, it is not yet known whether this distinction affects the 
processing and\or activity of these SUMOs. All highly expressed SUMO isoforms in 
Arabidopsis are engaged in conjugation reactions. Antibodies directed against 
SUMO1\SUMO2 (Lois et al. 2003, Murtas et al. 2003), and those directed against 
SUMO3 (Kurepa et al. 2003) indicate that these proteins form conjugates in vivo. Likewise, 
 
SUMO1
SUMO2
SUMO4
SUMO7
SUMO8
SUMO6
no mRNA 
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most similar 
to human 
SUMO 
families }
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expression of epitope-tagged SUMO5 allows detection of conjugates with this protein 
(Budhiraja, R. and Bachmair A., unpublished).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                                                      
 
Fig. 3 Alignment of SUMO protein sequences of Arabidopsis thaliana (taken form Navatchkova 
M., Budhiraja R., Coupland G., Eisenhaber F., Bachmair A., 2004). Conserved residues in the 
SUMO core have a yellow background; highly conserved residues are highlighted in red. EB1 and 
EB2 indicate positions of intron 1 and intron 2. Sec structure indicates the predicted secondary 
structure. Red triangles below the alignment indicate hydrophobic residues important for the 
stability of the compact ubiquitin-like core of SUMO. Asterisks below the alignment indicate amino 
acid residues that form a acidic patch over the SUMO surface, a feature that distinguishes the 
SUMO from other protein modifiers. Dots indicate spaces introduced to optimize alignment. As a 
maturation step, all SUMO proteins are predicted to be cleaved after the last conserved glycine 
residue at position 108. A cDNA splicing variant of SUM7 (not shown) contains the three amino-
acid insertion Glu-Leu-Gln at position EB2 (see text). 
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1.4 The Arabidopsis SUMO conjugation pathway 
 
 The pathway of conjugation of SUMO (termed sumoylation) is mechanistically 
analogous to ubiquitin conjugation (termed ubiquitylation or ubiquitination). The 
enzymes of the SUMO pathway, although similar to those of the ubiquitin pathway, are 
specific for SUMO and have no role in conjugating ubiquitin or any other ubiquitin-like 
proteins. Like ubiquitin, all SUMO forms are made as inactive precursor proteins. They 
mature by a carboxyl terminus cleavage event, which generates the mature form of the 
protein with exposed carboxyl terminus glycine residues. This cleavage reaction is 
catalyzed by a group of specific cysteine proteases, termed ULPs (ubiqutin-like protein 
processing enzymes) or SUMO-specific proteases (Li and Hochstrasser, 2000; Schwienhorst 
et al. 2000). Cleavage occurs after a conserved glycine residue (position 108 in Fig. 3). 
These double glycine residues are required for the formation of the SUMO-substrate 
linkage. Whereas most plant SUMO proteins have the same glycine-glycine motif at the 
cleavage site as present in animal and fungal SUMOs, the carboxyl termini of SUMO4, 
SUMO6 and SUMO7 deviate at the penultimate position. SUMO7 has an alanine-glycine, 
while SUMO4 and SUMO6 have a serine-glycine instead. The linkage between SUMO 
and its substrates is an isopeptide bond between the carboxyl terminus of SUMO and an 
ε-amino group of a lysine residue in the target protein.   
Sumoylation requires a specific set of enzymes which were first characterized in the yeast 
Saccharromyces cerevisiae (Fig. 4). The SUMO pathway begins with SUMO-activating 
enzyme (SAE), which carries out an ATP-dependent activation of the SUMO carboxyl 
terminus and then transfers the activated SUMO to a SUMO-conjugating enzyme (SCE) 
occasionally called Ubc9. SUMO is then transferred form SCE to a lysine residue in the 
substrate with the assistance of one of the several SUMO-protein ligases (E3). Many of 
the lysine residues where SUMO becomes attached are in the short consensus sequence 
ψKXE\D where ψ is a large hydrophobic amino acid, generally isoleucine, leucine or 
valine; K is the lysine residue that is modified; X is any residue; E is glutamic acid and D 
is aspartic acid (Rodriguez et al. 2001). Consistent with structural studies, showing direct  
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Fig. 4 The sumoylation cycle (taken form Navatchkova M., Budhiraja R., Coupland G., 
Eisenhaber F., Bachmair A., 2004). Multiple isoforms of SUMO exist in plants. All 
SUMOs are synthesized as inactive precursors that undergo proteolytic cleavage at their 
carboxyl terminus by SUMO-specific proteases (Step 1). Mature SUMO is activated by 
SUMO-activating enzyme (SAE), a heterodimer that has two large cavities (light blue 
boxes). One of the cavities can bind SUMO for activation (Step 2). The carboxyl terminus 
glycine of mature SUMO is activated by linkage to ATP, forming an AMP-SUMO 
intermediate. The SUMO carboxyl terminus is subsequently coupled to a cysteine residue 
of SAE (symbolized by a black dot) in a thioester linkage (Step 3). The second cavity of 
SAE can hold SUMO-conjugating enzyme (SCE). SUMO is transferred to the active-site 
cysteine residue of SCE, which dissociates from the complex (Step 4). SCE can directly 
bind to the substrates that contain a sumoylation consensus sequence (ψKXE\D) in an 
accessible position (Step 5a). So far, this sequence of events is mainly supported by in 
vitro data. Alternatively, SUMO protein ligases form a ternary complex with SCE and 
substrate, to catalyze sumoylation of substrate proteins at an ε-amino group of internal 
lysine residues (Step 5b). The sumoylation substrates are released (Step 6). SUMO-
specific proteases cleave off SUMO for re-use and restore the substrate to its previous 
form (Step7). 
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recognition of this consensus sequence motif by SCE, recombinant SAE, SCE and 
SUMO are sufficient for ATP-dependent SUMO modification of many substrates in vitro 
(Bernier-Villamor et al. 2002). SUMO ligases probably enhance specificity by interacting 
with other features of the substrate or by activating the SUMO-SCE complex (Reverter 
and Lima, 2005). 
Sumoylation is a reversible and dynamic process. The cleavage of SUMO from its target 
proteins (termed desumoylation or deconjugation) is catalysed by ULPs that specifically 
cleave at the carboxyl terminus of SUMO. In vitro, ULPs can catalyze the processing of 
SUMO, yielding its mature form as well as remove SUMO from the isopeptide-linked 
conjugate. 
            
1.4.1 SUMO-activating enzyme (SAE) 
 
Like the E1 of the ubiquitin conjugation pathway, the SUMO-activating enzyme activates 
SUMO at the carboxyl terminus glycine residue (Fig. 4) SUMO-activating enzyme (SAE) 
is a heterodimer of 40 kDa and 70 kDa (Dohmen et al 1995; Desterro et al. 1999). One 
protein shows similarity to the amino-terminal half, and the other to the carboxyl 
terminus half of the ubiquitin activating enzyme. Arabidopsis thaliana contains two 
genes for the smaller SAE subunit, SAE1a (At4g24940) and SAE1b (At5g50580). 
SAE1a and SAE1b are contained in segments that are duplicated between the 
chromosomes 4 and 5. The larger subunit of SAE, SAE2 (At2g21470) is represented by a 
single copy gene in the Arabidopsis genome (Table 1; Kurepa et al. 2003). The available 
structural data for the activation enzyme of RUB1, another protein modifier, suggests a 
mechanism for the activation that probably holds true for all the protein modifiers 
including SUMO (Walden et al. 2003). The SUMO-activating enzyme (SAE) catalyzes a 
three part reaction. First, the C-terminal carboxyl group of SUMO attacks ATP forming a 
SUMO C-terminal adenylate and releasing pyrophosphate. Next, the thiol group of the 
active site cysteine in the E1 attacks the SUMO adenylate, releasing AMP and forming a 
high energy thiolester bond between the E1 and the C terminus of SUMO. In the final 
reaction, the activated SUMO is transferred to a cysteine residue in the SCE. Most 
organisms contain a single SUMO-activating enzyme, which is required for the 
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conjugation of all SUMO isoforms. 
 
1.4.2 SUMO-conjugating enzyme (SCE) 
 
The second step after activation of SUMO is its transfer to the active site cysteine of 
SUMO-conjugating enzyme (SCE), to form a SUMO-E2 thiolester intermediate (Johnson 
and Blobel, 1997; Desterro et al. 1997). The SCE serves as a final donor in the final 
reaction in which SUMO is transferred to the substrate. The substrates are linked to 
SUMO via an isopeptide bond between the ε-amino group of an internal lysine residue 
and the activated SUMO carboxyl terminus. 
SCE is the only SUMO-conjugating enzyme in yeast and invertebrates, and most likely in 
vertebrates as well. Arabidopsis thaliana has one psuedogene and one active gene for the 
SUMO-conjugating enzyme (SCE1a). The enzyme is called Ubc9 in baker’s yeast 
Saccharomyces cerevisiae because of its similarity to ubiquitin-conjugating enzymes, and 
Hus5 in the fission yeast Schizosaccharomyces pombe. As the SUMO-activating enzyme, 
SCE is predominantly a nuclear protein (Seufert et al. 1995). The presence of only one 
gene in Arabidopsis is interesting in the light of the fact that the plant has eight distinct 
SUMO proteins. The presence of only one SCE contrasts with the ubiquitin pathway 
where the multiple ubiquitin-conjugating enzymes participate in ubiquitylation of distinct 
sets of substrates (Bachmair et al. 2001). The gene encoding SCE is essential in all 
organisms studied except in S. pombe, in which the SUMO conjugation is not required 
for viability (Seufert et al. 1995; Jones et al. 2002; Ho and Watts, 2003). Current data 
suggest that in animals and probably also in plants, SUMO conjugation reactions in vivo 
as well as in vitro proceed without the assistance of protein ligases (discussed later in the 
text). SCE has a strong overall positive charge. A patch surrounding the active site 
cysteine of SCE binds directly to the ψKXE\D consensus sequence in the substrate (ψ is a 
large hydrophobic amino acid, generally isoleucine, leucine or valine; K is the lysine 
residue that is modified; X is any residue; E is glutamic acid and D is aspartic acid). In 
addition to the consensus, other properties of the substrate protein sequence appear 
necessary. For instance, X-ray structure data of an SCE-substrate complex indicate that in  
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order to specifically attract SUMO, this consensus sequence has to be positioned in a large 
and accessible loop (Bernier-Villamor et al. 2002). Apart from sumoylation at the 
consensus sites, an increasing number of examples are found where the sumoylated 
lysine residues are not positioned in a canonical consensus sequence. These sumoylation 
events are prime candidates for in vivo dependence on SUMO ligases. 
 
1.4.3 SUMO ligases  
 
SUMO ligases are enzymes that bind, directly or indirectly, specific protein substrates 
and promote the transfer of SUMO from a thiolester intermediate to amide linkages with 
proteins. While SUMO-activating enzyme (SAE) and SUMO-conjugating enzyme (SCE) 
were shown to be sufficient for sumoylation of various substrates in vitro, recent studies 
have demonstrated that in vivo most of the SUMO conjugating reactions require SUMO 
ligase activity. So far, three types of SUMO ligases have been identified in animals and 
fungi, namely SIZ\PIAS, RanBP2 and Pc2, all of which interact with SCE and enhance 
sumoylation both in vivo and in vitro. 
The SIZ group (prototype members are SIZ1 and SIZ2\NFI1 of Saccharomyces 
cerevisiae, and the PIAS family of animals) is similar to the major class of ubiquitin 
ligases in that it uses a RING-like domain for binding of the SCE-SUMO complex 
(Johnson and Gupta 2001; Kahyo et al. 2001). Arabidopsis homologs of this goup of 
ligases are listed in Table 1. The second type RanBP2 (Ran-binding protein 2; Pichler et 
al. 2002), does not display any sequence relation to SIZ-type SUMO ligases or ubiquitin 
ligases. RanBP2 is located at the cytoplasmic filaments of the nuclear pore complex, 
where it interacts with sumoylated RanGAP and the GTPase. RanGAP was itself one of 
the SUMO targets to be identified (Saitoh et al. 1998). This type of SUMO ligase is 
probably restricted to animals, because its prominent substrate RanGAP is apparently not 
sumoylated in fungi, and a similar situation may hold in plants. In particular, the SUMO 
acceptor domain is lacking in plant RanGAP (Rose and Meier, 2001). 
The polycomb group (PcG) protein Pc2 was reported to be the third type of SUMO ligase 
which is structurally unrelated to SIZ\PIAS or RanGAP and to ubiqutin ligases (Kagey et 
al. 2003). PcG proteins form large multimeric complexes, which are detectable microscopically  
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as discrete foci, called PcG bodies within the cell. It is difficult to identify candidate 
ligases of this type in Arabidopsis because a precise definition of the subdomain(s) involved in  
                                             
      
  
 
 
 
 
 
 
 
 
 
           
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
        
 
Table 1. Listing and sequence characterization of Arabidopsis thaliana SUMO-related proteins and 
predicted proteins involved in SUMO conjugation (taken form Navatchkova M., Budhiraja R., 
Coupland G., Eisenhaber F., Bachmair A., 2004). Proteins of a potential orthology relationship in 
Saccharomyces cerevisiae and Arabidopsis thaliana have been identified in an approach as reciprocal best 
hits in these two proteomes (Tatusov et al. 2003). Further Arabidopsis thaliana genome searches have 
been used to confirm the completeness of the test. The genomic map view has been derived from the 
NCBI Mapviewer (Wheeler et al. 2004). Domain architectures have been determined using Conserved 
Domain Database (CDD) queries (Wheeler et al. 2004). Abbreviations: Chr.- Chromosome, NA - not 
available. 
Yeast  
Homologs Name BAC locus Chr. locus 
GB accession 
(protein) 
Chromosome 
Map-view 
Domain 
Architecture 
SUMO       
SMT3p / Q12306 SUM1 F10M23 At4g26840 NP_194414   
 SUM2 MCO15 At5g55160 NP_200327   
 SUM3 MCO15 At5g55170 NP_200328   
 SUM4 K24G6 At5g48710 NP_199682   
 SUM5 F24L7 At2g32765 NP_565752   
 SUM6 K24G6 At5g48700 NP_199681   
 SUM7 MWJ3 At5g55855* NA   
 SUM8 MWJ3 At5g5585x* NA   
 SUM9 F5I10 At4g0027x* NA  NA 
SUMO-like domain protein      
Esc2p / NP_010650       
         T22E19 At1g68185 NP_564924   
SUMO activating enzyme      
Aos1p / NP_015506    SAE1a F13M23 At4g24940 NP_567712      
    SAE1b MBA10/ MFB16 
At5g50580/ 
At5g50680 NP_568741      
Uba2p / NP_010678       
    SAE2 f3k23 At2g21470 NP_179742      
SUMO conjugating enzyme      
Ubc9p / NP_010219 SCE1a T10K17 At3g57870 NP_191346   
 SCE1b T1E22 At5g02240* NA  NA 
SUMO ligase candidates      
Nfi1p / Q12216 SIZ1 MUF9 At5g60410 NP_200849   
 PIASlike1 F7G19 At1g08910 NP_172366   
 PIASlike2 MBK23 At5g41580 NP_198973   
 Ubiquitin-like (PF00240)  Ubiquitin-like (subsignif)  ThiF (PF00899) 
 MoeB-similar  UBACT (PF02134)  UQ_con (PF00179) 
 SAP (PF02037)  PHD (PF00628)  zf-MIZ (PF02891) 
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 sumoylation is not available. Furthermore, similarity of Arabidopsis proteins to domains 
common to all polycomb members may be insufficient to define the functional homologs 
of PcG because most polycomb proteins have no known SUMO ligase activity. 
 
1.4.4 SUMO proteases - desumoylation 
        
The cleavage of SUMO from its target proteins is catalyzed by SUMO proteases. SUMO 
cleaving enzymes have at least two functions in sumoylation. They remove SUMO from 
proteins, making the modification reversible, and also provide a source of free SUMO to 
be used for conjugation to other proteins. All known SUMO-cleaving enzymes contain a 
~ 200 amino acid domain (Ulp domain), which has the SUMO cleaving activity 
(Mossessova and Lima, 2000). The Ulp domain does not share sequence similarity with 
the enzymes that cleave ubiquitin. Instead, it is distantly related to number of viral 
proteases (Li and Hochstrasser, 1999). 
Two desumoylating enzymes Ulp1 and Ulp2 (ubiquitin-like modifier proteases) have 
been identified in baker’s yeast. In vitro, both Ulp1 and Ulp2 can catalyze the carboxyl 
terminus processing of SUMO, and both enzymes can remove SUMO from isopeptide-
linked conjugates (Li and Hochstrasser, 2000). Seven genes in mammalian genomes 
encode proteins with Ulp domains. These proteins are called SENPs (sentrin proteases). 
The homologs of SUMO proteases in Arabidopsis are called AtULPs (Kurepa et al. 
2003) Not all members of the SENP group are specific for SUMO. For instance, SENP8 
was found to cleave at the carboxyl terminus of the small ubiquitin-like modifier NEDD8 
(Mendoza et al. 2003). NEDD8 is called RUB 1 in most organisms including Arabidopsis 
(Rao-Naik et al. 1998). In plants, the enzyme specificity is even more difficult to evaluate 
since data base searches have identified at least 67 genes in Arabidopsis with similarity to 
the SUMO protease domain. Thus, there has been a huge expansion in this class of 
protease, and it is unlikely that all of them are specific for SUMO. However, one of these 
protease genes, ESD4 (early in short days 4), has been functionally characterized to 
encode a SUMO protease (Murtas et al. 2003). Subcellular localization has been 
identified as a critical aspect of SUMO protease function (Huang and Dasso, 2000; Li and 
Hochstrasser, 2003). A recent report that the plant SUMO protease ESD4 specifically localizes  
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to the nuclear periphery suggests a similar situation in plants (Murtas et al 2003). Table 2 
lists seven likely candidates, and groups five genes with yeast proteases Ulp1 and Ulp2. 
AtUlp1c and AtUlp1d (Kurepa et al. 2003) are close homologs, located in segmentally 
duplicated regions of chromosome 1. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 1.5 Substrate specificity in sumoylation 
 
SUMO is conjugated to most target proteins at a lysine residue in a consensus sequence 
ψKXE\D but there are other determinants involved in target selection as well. The 
glutamic acid is the most highly conserved position other than lysine. In some cases, a 
glutamine to aspartic acid mutation in the consensus sequence significantly reduces 
sumoylation (Sapetschnig et al. 2002), although a few sequences are sumoylated 
(Johnson and Blobel, 1999). The ψKXE\D motif can directly bind the SUMO-
conjugating enzyme (Sampson et al. 2001). This direct interaction explains why so many  
Yeast  
Homologs Name Chr. locus Domain Architecture 
SUMO cleaving protease candidates 
ULP1p / Q02724 ESD4 At4g15880  
 ULP1a/EL1 At3g06910  
 ULP1b At4g00690  
ULP2p / P40537 ULP2like1 At4g33620  
 ULP2like2 At1g09730  
 ULP1c At1g10570  
 ULP1d At1g60220  
 SENPlike1 At5g60190  
 Peptidase_C48 (PF02902) 
 
Table 2. SUMO-specific proteases in Arabidopsis and related proteins in yeast.
The prototype enzymes are ULP1 and ULP2 from baker’s yeast. Animal enzymes 
are called SENPs (Sentrin proteases). Arabidopsis thaliana has at least 67 genes 
with similarity to the SUMO-specific protease domain. 
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sumoylation substrates have been identified via their interaction with SCE in the yeast 
two hybrid screen. Furthermore, it accounts for SAE and SCE together being sufficient to 
sumoylate many proteins at the consensus motif in vitro in the absence of SUMO ligases. 
Remarkably, a ψKXE\D sequence and nuclear localization sequence (NLS) are sufficient 
to target an artificial substrate for sumoylation, indicating that the requirements for 
SUMO conjugation can be very simple (Rodriguez et al. 2001). The ψKXE\D motif is 
very short and found in many proteins, most of which are not targeted by SUMO. For 
example, of the 5884 open reading frames (ORFs) in Saccharomyces cerevisiae, there are 
2799 sequences of the form ψKXE distributed in 1931 different ORFs. Thus, in addition 
to the consensus motif, other interactions between the substrate and SCE may be relevant 
for substrate selection. For instance, the crystal structure of the RanGAP1-SCE complex 
(substrate-SCE complex) indicates that, in order to specifically attract SUMO, this 
consensus sequence has to be positioned in a large and accessible loop (Bernier-Villamor 
et al. 2002). Several proteins are also modified at sites other than ψKXE. The replication 
processivity factor PCNA has two sumoylation sites, one conforming to the consensus 
sequence and other at a TKET sequence (Hoege et al. 2002). Other reports confirm 
sumoylated proteins TEL, PML, Smad4 and the Epstein barr virus BZLF1 protein to have 
sumoylation sites at sequences TKED, AKCP, VKYC and VKFT, respectively (Adamson 
et al. 2001; Kamitani et al. 1998; Lin et al. 2003; Rui et al. 2002; Chakrabarti et al. 2000). 
Moreover, some sumoylated proteins such as Mdm2, Daxx, CREB, and CTBP2 do not 
contain a  ψKXE sequence, others are still sumoylated when all consensus sites are 
mutated (Kagey et al. 2003; Miyauchi et al. 2002; Jang et al. 2002; Rangasamy et al. 
2000; Xirodimas et al. 2002, Comerford et al. 2003). It is not clear how these 
nonconsensus sites are recognized. 
 
1.6  Substrates and functions of SUMO protein modification 
 
Since the identification of the first SUMO modified protein, RanGAP in 1996 (Matunis 
et al. 1996), a large number of proteins have been shown to be post-translationally 
modified by SUMO, and new substrates of SUMO modification continue to be identified 
at a rapid pace. Some of the proteins known to be modified by SUMO are listed in Fig 5.  
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Many of the known targets of SUMO are mammalian proteins involved in signal 
transduction and transcriptional regulation. Others are involved in DNA damage repair 
(Hoege et al. 2002), chromosome segregation (Khodairy et al. 1995), blocking ubiquitin- 
mediated events (Johnson 2004), etc. In this last capacity for example, IκB, the inhibitor 
of the nuclear factor κB transcriptional activator, can be modified by both SUMO and 
ubiquitin to regulate its half life (Desterro et al. 1998). To date, in plants there are no 
specific proteins reported to be modified by SUMO, but there are possibly many plant 
SUMO targets that await identification. However, there have been studies and evidence 
that support a role of SUMO during response of plants to various environmental stresses. 
When Arabidopsis is exposed to heat shock, hydrogen peroxide, ethanol or the amino 
acid analogue canavanine, the levels of SUMO1\2 conjugates are significantly and 
reversibly increased (Kurepa et al. 2003). Arabidopsis plants overexpressing SUMO1 were 
subsequently shown to be less sensitive to the hormone abscisisc acid, further supporting 
a role for sumoylation in stress response (Lois et al. 2003). Several species of pathogenic 
bacteria for both plants and animals have been recently reported to secrete proteases 
related to ULPs into the host upon infection, with this secretion attenuating the 
accumulation of SUMO conjugates in planta (Orth et al. 2000; Hotson et al. 2003). The 
recent discovery that the Arabidopsis ESD4 locus, which promotes early flowering in 
short days when mutated, encodes a nuclear localized protein related to Ulp family of 
SUMO specific protease suggests that desumoylation of conjugates may also be 
important to floral induction (Murtas et al. 2003). 
What appears to emerge from the analysis of SUMO targets is that their modification 
alters their activities, their ability to interact with other proteins, or their subcellular 
localization. An in vitro sumoylation system based upon purified proteins of E. coli 
extracts expressing a complete set of enzymes may help to understand how the 
biochemical properties of a given substrate are changed by sumoylation (Uchimura et al. 
2004). 
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1.7   Strategies to analyze SUMO conjugation in Arabidopsis thaliana 
 
The use of biochemical protocols and molecular genetics in the model plant Arabidopsis 
thaliana has proved a powerful approach to study the SUMO conjugation pathway. 
Arabidopsis thaliana, also known as Mouse-ear or Thale cress, is a member of the  
 
Fig. 5 SUMO modified proteins (taken from Seeler et al. 2003). Some of the many 
proteins that have been found to be post-translationally modified by SUMO are depicted 
in the diagram by function\localization. Many SUMO modified proteins function in 
regulation of transcription, chromatin structure, maintenance of genome and signal 
transduction. All proteins are of mammalian origin unless specifically indicated by 
Saccharomyces cerevisiae (Sc), Shizosaccharomyces pombe (Sp), Drosophila (Dm), and 
Dictyostelium (Dd). 
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Brassicaceae family, and was chosen as a model organism for many reasons. The major 
advantages for experimental purpose are its small size, short generation time, diploid 
nature, a small genome (125 Mb) and ability to produce a large number of seeds (Schmidt 
1995). Furthermore, after years of research by scientific groups worldwide, thousands of 
mutants and research material are available. In addition, the entire genome of this non- 
agronomically relevant plant has been sequenced and information of different metabolic, 
regulatory pathways and other specific processes is accessible. 
This study employs two different strategies to analyze the SUMO conjugation system of 
Arabidopsis. The first approach is aimed at purification and identification of proteins that 
are sumoylated in this plant. The second strategy to gain more insights into the process of 
sumoylation in Arabidopsis, is by interfering with the genetic components of the 
sumoylation machinery. It is aimed at manipulation of one or more genes involved in the 
sumoylation pathway. This may hint at the relevance of sumoylation in growth and 
development of Arabidopsis thaliana. 
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2.    MATERIAL AND METHODS 
 
2.1    Material 
 
2.1.1 Plant plasmid constructs 
 
  The Arabidopsis thaliana plants and their ecotypes used in this study are listed in Table 3. 
 
 
 
      CONSTRUCT 
 
ECOTYPE 
 
        DESCRIPTION 
  
OBTAINED 
FROM 
       
        Wild-type 
     
    Col 
 
Wild type plants without transgene 
 
Andreas Bachmair 
 
       
        Wild-type 
     
    Ws 
 
Wild type plants without transgene 
 
Christian Hardtke 
 
    
 
       pHi SUMO1GG 
     
 
    Col 
 
SUMO1 transgene with double 
glycine amino acid residues at the 
carboxyl terminus; 3x HA and His6 
affinity tags at the amino terminus; 
constitutive expression 
 
 
 
Andreas Bachmair 
 
 
 
      pHi SUMO1AA 
      
 
    Col 
 
SUMO1 transgene with double 
alanine amino acid residues at the 
carboxyl terminus; 3x HA and His6 
affinity tags at the amino terminus; 
constitutive expression 
 
 
 
Andreas Bachmair 
 
 
 
  
    pHi SUMO1AG 
   
 
     Col 
 
SUMO1 transgene with alanine- 
glycine amino acid residues at the 
carboxyl terminus; 3x HA and His6 
affinity tags at the amino terminus; 
constitutive expression 
 
 
 
 
Andreas Bachmair 
 
 
 
    pHi SUMO1GA 
   
 
    Col 
 
SUMO1 transgene with glycine- 
alanine amino acid residues at the 
carboxyl terminus; 3x HA and His6 
affinity tags at the amino terminus; 
constitutive expression 
 
 
Andreas Bachmair 
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 CONSTRUCT 
 
ECOTYPE 
 
           DESCRIPTION 
 
OBTAINED 
FROM 
 
 
 
   pHi  SUMO1Stop 
 
 
 
   Col 
 
SUMO1 transgene with  deletion of 
the last two amino acid residues at 
the carboxyl terminus; 3x HA and 
His6 affinity tags at the amino 
terminus; constitutive expression 
 
 
 
  Andreas Bachmair 
 
 
 
 pER8 tag3 SUMO1 
 
 
   Col 
 
SUMO1 transgene with Strep, 
3xHA, His8 affinity tags at the 
amino terminus; 
inducible expression ( estradiol) 
 
 
   This work 
 
 
  pER8 tag3 SUMO3 
 
   Col 
 
SUMO3 transgene with Strep, 
3xHA, His8 affinity tags at the 
amino terminus;  
inducible expression (estradiol) 
 
 
   This work 
 
 
  pER8 tag3 SUMO5 
 
 
    Col 
 
SUMO5 transgene with Strep, 
3xHA, His8 affinity tags at the 
amino terminus;  
inducible expression (estradiol) 
 
 
   This work 
 
 
 pER8 tag3 SUMO1     
GG(Q93A) 
 
   
   
    Col 
 
SUMO1 GG transgene with 
substitution of glutamine at 
position 93 with alanine; Strep, 
3xHA, His8 affinity tags at the  
amino terminus; 
inducible expression (estradiol) 
 
  
   This work 
 
 
 
   pHi  SUMO6 
 
 
 
    Col 
 
SUMO6 transgene with introns 
and Strep, His6, 3xHA affinity 
tags at the amino terminus; 
constitutive expression  
 
 
  Andreas Bachmair 
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CONSTRUCT 
 
ECOTYPE 
 
           DESCRIPTION 
 
OBTAINED 
FROM 
  
 
  pHi SUMO7  
 
     
     Col 
 
SUMO7 transgene with introns  
and Strep, His6, 3x HA affinity 
tags at the amino terminus; 
constitutive expression 
 
Andreas Bachmair 
 
 
 
 pHi SUMO7v 
 
 
    Col 
 
SUMO7 transgene with introns and 
three amino acid insertion ELQ at 
the second intron position; Strep, 
His6 and 3x HA affinity tags at the 
amino terminus; 
constitutive expression 
 
 
Andreas Bachmair 
 
 
 
pHi SUMO1 (Q93A) 
 
 
     Col 
 
SUMO1 transgene with substitution 
of glutamine at position 93 with 
alanine; 3xHA, His6  affinity tags at 
the amino-terminus; constitutive 
expression 
 
 
     This work 
 
 
pHi SUMO1 (Q93D)
  
 
 
     Col 
 
SUMO1 transgene with substitution 
of glutamine at position 93 with 
aspartic acid; 3xHA, His6  affinity 
tags at the amino terminus; 
constitutive expression 
 
 
    This work 
 
 
pHi SUMO1 (Q93L) 
 
 
     Col 
 
SUMO1 transgene with substitution 
of glutamine at position 93 with 
leucine; 3xHA, His6  affinity tags at 
the amino terminus; constitutive 
expression 
 
 
   This work 
 
 
pHi SUMO1 (Q93R) 
 
     
   Col 
 
SUMO1 transgene with substitution 
of glutamine at position 93 with 
arginine; 3xHA, His6  affinity tags 
at the amino-terminus; constitutive 
expression 
 
    This work 
 
     35S: SCE 
 
   Ws 
 
Constitutively overexpressed SCE 
 
Christian Hardtke 
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 CONSTRUCT 
 
ECOTYPE 
 
          DESCRIPTION 
 
OBTAINED 
FROM 
 
 
 35S: SCE (C94S) 
 
      
    Ws 
 
Constitutively over expressed SCE 
with a mutated active site 
cysteine at position 94 in the 
gene to serine,  
 
Christian Hardtke 
 
 
               Table 3. Listing of the Arabidopsis thaliana plants used in this study 
 
 
2.1.2 Bacterial plasmid constructs  
 
The bacterial plasmid constructs employed in this study are listed in Table 4. 
 
 
  
      CONSTRUCT 
 
       DESCRIPTION 
 
                   OBTAINED  
                       FROM 
 
  pET-9d tag 3 SUMO1          
 
SUMO1 transgene with 
Strep, 3xHA, His8  affinity 
tags at the amino terminus  
  
            This work 
  
  pET-9d tag 3 SUMO3          
 
SUMO3 transgene with 
Strep, 3xHA, His8  affinity 
tags at the amino terminus 
   
            This work 
 
  pET-9d tag 3 SUMO5          
 
SUMO5 transgene with 
Strep, 3xHA, His8  affinity 
tags at the amino terminus 
   
            This work 
 
  pET-9d tag 3 SUMO6          
 
SUMO6 transgene with 
introns and containing Strep, 
3xHA, His8  affinity tags at the 
amino terminus 
   
            This work 
 
 pET-9d tag 3 SUMO7           
 
SUMO7 transgene with 
introns and containing Strep, 
3xHA, His8  affinity tags at the 
amino terminus 
   
            This work 
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      CONSTRUCT 
 
       DESCRIPTION 
 
   OBTAINED  
   FROM 
 
  pET-9d tag 3 SUMO7v        
SUMO7v transgene with 
introns and the three amino 
acid insertion in the second 
intron; Strep, 3xHA, His8  
affinity tags at the amino-
terminus 
   
     
     This work 
 
    pACYC177-SAE1a 
 
Smaller SAE subunit with  
His6 affinity tag 
  
     This work 
 
   pDEST-17 SAE2 
 
Larger SAE subunit with  
His6 affinity tag 
   
      Yong-Fu Fu  
     
    pSK SCE 
 
 
 SCE  
   
      Andreas Bachmair 
 
    pQE-30 SCE 
 
 
SCE with His6 affinity tag 
       
      This work 
 
     pET-9d SCE 
 
SCE in E. coli expression 
vector pET-9d 
    
     This work 
 
 
               Table 4. Listing of bacterial plasmid constructs used in this study 
 
 
 
2.1.3   Plasmid vectors used 
 
pACYC-177 (New England Biolabs) 
 
pACYC-177 is an E. coli plasmid cloning vector containing the p15A origin of 
replication. This allows pACYC-177 to coexist in cells with plasmids of the ColE1 
compatibility group. It is a low copy number vector, at about 15 copies per cell. Selection 
markers are ampicillin and kanamycin resistance. The vector is about 3941 bp (Fig. 6).   
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pBluescript II (Stratagene) 
 
This vector was used for routine cloning procedures. In addition to its large polylinker, it 
allows α-complementation of an N-terminal deletion of lac-Z (beta galactosidase gene). 
Different orientations of the polylinker are available; the selectable marker is ampicillin 
resistance. The vector is about 2961 bp in size (Fig. 7). 
 
 
                                                                   
 
 
Fig. 6 Schematic drawing of pACYC-177            Fig. 7 Schematic drawing of pBIIKS 
Representative restriction sites are shown.              Reresentative sites are shown 
Selective marker is ampr and kanr                            Selective marker is ampr                                 
    Vector size is 3941 bp                                            Vector size is 2961 bp                                      
 
    
 
pDEST-17 (Invitrogen) 
 
Cloning and overexpression of Arabidopsis SAE1 in E. coli was done in pDEST-17 
expression vector. It allows easy purification of the fusion protein due to the incorporated 
His6 sequence. The promoter used contains the E. coli phage T7 promoter. It originally 
contains two selection markers, namely chloramphenicol and ampicillin resistance. 
However, chloramphenicol resistance is lost when a sequence is inserted by recombination. 
This vector has a size of 6354 bp (Fig. 8). 
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pER-8 (Zuo et al. 2000) 
 
pER-8 is a binary T-DNA cloning vector for expression under the control of an estradiol 
inducible promoter. It is 11784 bp pairs in size. Selectable markers for the vector are 
spectinomycin (bacteria) and hygromycin (plants) resistance. Both Stul sites (in MCS and 
ER region) are blocked by dcm methylation (Fig. 9). 
 
 
                    
 
                                    
 
  
Fig. 8 Schematic drawing of pDEST-17               Fig. 9 Schematic drawing of pER-8 
Relevant restriction sites are shown.                        Relevant restriction sites are depicted 
Selective markers are chlr and ampr                          Vector size is 11784 bp 
Vector size is 6354 bp 
 
 
 
 
pET-9a (Novagen) 
 
The pET-9a expression vector carries a N-terminal T7 tag sequence and a BamHI cloning 
site. Unique sites have been shown on the circle map (Fig. 10) with pBR322 origin of 
replication. The promoter used contains the E. coli phage T7 promoter. Selective marker 
is kanamycin resistance and the size of the vector is 4341 bp. 
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pHi (Schlögelhofer and Bachmair, 2002) 
 
pHi is a binary T-DNA vector used for transformation of A. thaliana. It contains a 2x 
CaMV35S promoter and the corresponding polyadenylation signal. The whole cassette is 
flanked by Hind III sites as originally constructed in the plant expression vector pRT-103 
(Schlögelhofer and Bachmair, 2002). The selective marker for maintaining in E. coli is 
kanamycin resistance. The T-DNA borders are flanking the HPT (Hygromycin 
phosphotransferase) for selection in plants. The vector also contains sequences from the 
ribosomal gene cluster as transcription enhancers (USR; Fig. 11). 
 
                                  
 
 
Fig. 10 Schematic drawing of pET-9a   Fig. 11 Schematic drawing of pHi 
Unique restriction sites are shown.    Unique restriction sites are shown 
Abbreviations are: ori, origin of              Selective marker is kanr    
replication; Kan, kanamycin resistance.   Vector size is 14 Kb  
Vector size is 4341 bp 
 
                
                                                               
                                                                                                             
pQE-30 (Qiagen) 
 
For some experiments concerning overexpression of proteins in E. coli, expression vector 
pQE-30 was used. The His6 sequence is fused to the expressed protein which allows easy 
purification of fusion proteins via affinity chromatography using immobilized Zn++ 
cations. The promoter contains the E .coli phage T5 promoter with two lac operator sequences 
HPT  2x CaMV USR Nos t 
MCS
Hind III
XbaI, BamHI, SmaI, KpnI, XhoI 
EcoRIHind III
pBIBhyg 
KpnI 
From p2RT103
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This allows induction of expression using IPTG. At the 3´ end of these regulatory 
sequences, a multiple cloning site can be found. The cassette is terminated by stop codons 
in all the 3 ORFs and by t0 trascriptional terminator from phage lambda. The selective 
marker used is ampicillin resistance (Fig. 12). 
 
 
                                   
  
                                           
2.1.4  Oligonucleotides used 
 
SUMO isoforms 
 
SUMO1:  
dn: CTAGCCATGGCTCATCATCATCACCATCATATGTCTGCAAACCAGGAGGA 
up: GATCGGTACCGAGTAGTAGTAGTGGTAGTATACAGACGTTTGGTCCTCCT 
 
 
SUMO midup:  GACTTTGAGATTGATGTGAGCTCCT 
SUMO mid dn: GTTCCATCCTGCCCCGTCTCCGGCT 
 
 
SUMO3: 
dn: GCCGGTACCATGTCTAACCCTCAAGATGACAAGCCCATC 
up: TCGTCTAGATTCAACCACCACTCATCGCCCGGCACGCATCTATCACATC 
 
 
SUMO5: 
dn: GCCGGTACCATGGTCAGTTCCACAGACACAATCTCTGCT 
up: TGCTCTAGATTCAGCCACCACCAAGTTCCATGACCATACAGATCTCATC 
 
Fig. 12 Schematic drawing of pQE-30 
Representative restriction sites are shown. 
Selective marker is ampr 
Vector size is 3462 bp 
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SUMO6: 
dn:  GCCGGTACCATGTCAACGAAGAGCAGTAGTATTCATGGAA 
up:  TGCTCTAGATTCAACCACTTTCTTGAGGCAACAATGCATCGATTTGATC 
 
 
SUMO7: 
dn: GCCGGTACCATGTCGGCAGCTGACAAAAAACCGTTGATT 
up: TGCTCTAGATTCACCCTGCTATTTGGTCAACAAATGCATCGATTTCATC 
 
C-terminal SUMO variants 
 
GlyGly:  CTAGATCAGCCACCAGTCTG 
 
AlaGly: CTAGATCAGCCAGCAGTCTG 
 
GlyAla: CTAGATCAGGCACCAGTCTG 
 
AlaAla: CTAGATCAGGCAGCAGTCTG 
 
Stop:      CTAGATCATTAACTCTG 
 
 
SUMO variants potentially inhibiting deconjugation 
 
 
SUMO (Q93A) top:        CGATGCGATGCTCCATGCTACTGGTGGCTGATT 
SUMO (Q93A) bottom:  CTAGAATCAGCCACCAGTAGCATGGAGCATCGCAT 
 
SUMO (Q93D) top:        CGATGCGATGCTCCATGATACTGGTGGCTGATT  
SUMO (Q93D) bottom:  CTAGAATCAGCCACCAGTATCATGGAGCATCGCAT 
 
SUMO (Q93L) top:         CGATGCGATGCTCCATTTGACTGGTGGCTGATT 
SUMO (Q93L) bottom:   CTAGAATCAGCCACCAGTCAAATGGAGCATCGCAT 
 
SUMO (Q93R) top:         CGATGCGATGCTCCATAGAACTGGTGGCTGATT 
SUMO (Q93R) bottom:   CTAGAATCAGCCACCAGTTCTATGGAGCATCGCAT 
 
 
SUMO activating enzyme 
 
SAE2B dn:  
CTGTACACCATGGAGATCTGAGCCTGCTTCTAAGAAGAGAAGACT   
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SAE link up: 
GAGTCTATCTCCGTCCATGGCACCATGGTGATGATGGTGATGGGTCATTATTC
AACTCTTATCTTCTT  
 
 SAE2B dn2: 
CCATGGTGTACAGGCCAGATCTGAGCCTGCTTCTAAGAAGAGAAGACT 
 
SAE link up2: 
GAGCTCATCTCCGTCCATGGCACCATGGTGATGATGGTGATGGGTCATTATTC
AACTCTTATCTTCTT 
 
SUMO conjugating enzyme 
 
SCE 1dn: CGTACCATGGCTAGTGGAATCGCTCGTGGTC 
 
SCE 1up: TCCCCCGGGTTAGACAAGAGCAGGATACTGCTTGGACT 
 
Affinity tags 
 
Strep SUMO top: CATGGCTTGGTCTCATCCACAATTCGAAAAGGG  
 
Strep SUMO bottom: CATGCCCTTTTCGAATTGTGGATGAGACCAAGC 
 
2.1.5   Bacterial strains 
 
 Escherichia coli 
XL1-blue (Stratagene) was used for all routine E. coli transformations. 
Genotype: F´ :: Tn10 proA+B+ lacIq ∆(lacZ) M15/recA1endA1 gyrA96 (Nalr) thi hsdR17 
(rK-mK+) glnV44 relA1 lac  
BL21 (DE3) or BL21 (DE3) pLysS (Novagen) was used  for transformation with 
expression vectors carrying the insert. 
Agrobacterium tumefaciens 
C58C1-pCV 2260 strain (selection with 50µg\ml Kanamycin and 100µg\ml Rifampicin) 
was used for transformation. 
 
2.1.6   Plant and bacterial growth media  
 
Plant growth medium 
Germination medium: 4.33g\l Murashige and Skoog salt mixture, 1% (w\v) sucrose, 
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100µg\ml inositol, 1µg\ml thiamine, 0.5µg\ml pyridoxine, 0.5µg\ml nicotinic acid, 
0.5mg\ml 2-[ N-Morpholino]-ethanesulphonic acid (MES), 0.9%(w\v) agar, pH 5.7 
 
Bacterial growth medium 
Escherichia coli 
2xTY (liquid medium): 1.6% (w\v) Bacto tryptone (Difco), 1% (w\v) Bacto yeast extract 
(Difco), 0.5 % (w\v) NaCl, pH 7.5 
2xTY (solid medium): As above with 1.5% Bacto agar (Difco) 
Agrobacterium tumefaciens 
YEB (liquid medium: 0.5%(w\v) Bacto beef extract (Difco), 0.1% (w\v) Bacto yeast 
extract (Difco), 0.5% (w\v)  Bacto Peptone (Difco), 0.5% (w\v) Sucrose, pH 7.2 
Supplemented with 10mM MgSO4 after autoclaving. 
YEB (solid medium): As above with 1.5% Bacto agar (Difco) 
 
2.1.7  Chemicals and Enzymes 
 
Unless otherwise stated, all chemicals were supplied by Sigma, Merck, Roth, Invitrogen 
or Duchefa. Enzymes were supplied by New England Biolabs, Fermentas or Roche. 
 
2.1.8 Antibiotics 
 
Bacterial selection            Working concentration                            Solvent 
Ampicillin (Amp)              50µg\ml      dissolved as powder in autoclaved medium  
Kanamycin (Kan)              50µg\ml      water 
Rifampicin (Rif)                50µg\ml                   water 
Chloramphenicol (Chl)     50µg\ml                   ethanol 
Plant selection 
Kanamycin                         25µg\ml                   water 
Hygromycin                        25µg\ml                  supplied as liquid 
Gentamycin                        50µg\ml                   water 
Cefotaxime Na-salt            200µg\ml                 water 
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All antibiotics were supplied by Duchefa or Sigma and antibiotics were filtered sterilized 
before use; except hygromycin (Roche, supplied sterile). 
 
 2.1.9  Herbicide 
 
Bialaphos (Basta): active ingredient: glucofosinate-ammonium 
                               Working concentration: 100mg\l   
 
2.2        METHODS 
 
2.2.1.1  Isolation of Plasmid DNA from E. coli (Alkaline lysis method) 
 
A single bacterial colony was inoculated in 3ml of 2xTY (liquid medium) containing 
appropriate antibiotics, and grown overnight at 37°C. 1.5ml of the culture was transferred 
to an Eppendorf tube and the bacterial cells were pelleted by centrifugation at 14,000 rpm 
for two minutes in a microfuge (Eppendorf). The pellet was resuspended in 100µl of  
GTE buffer (50mM glucose, 25mM Tris.Cl  pH 8.0, 10mM EDTA) and mixed properly 
using a vortex shaker. The resuspended cells were incubated for 5-10 minutes at room 
temperature. 200µl of freshly prepared alkaline-SDS solution (0.2N NaOH, 1% SDS) 
was added, mixed slowly by inverting the tube five to six times, and incubated on ice for 
5 minutes. Following incubation on ice, 150µl of acetate solution (5M acetic acid is 
added to 5M potassium acetate solution until pH is ~ 4.8) was added to the tubes, which 
were incubated for 15 minutes on ice. The samples were then centrifuged at 14,000 rmp 
for 5 minutes at 4oC to remove the cell debris. The supernatant was transferred to an 
Eppendorf tube and the DNA was ethanol precipitated by addition of 1ml ethanol (100% 
ethanol; RT). The DNA pellet was dissolved in 20-30µl dH2O. One volume of 5M 
NH4OAc was added to the above dissolved DNA pellet, incubated for five minutes at 
room temperature and centrifuged at 14,000 rpm for 5 minutes (RT). The supernatant was 
transferred to a new Eppendorf tube and 0.6 volumes of isopropanol were added and the 
contents of the tube were mixed gently. Following 10 minute incubation at RT, the 
isopropanol-precipitated DNA was centrifuged for 10 minutes at 4oC. The DNA pellet 
was washed with 70% ethanol (cold), re-pelleted and dried in vacuum. The dried DNA 
pellet was finally dissolved in 20-30µl of dH2O or TE buffer (10mM Tris Cl, 1mM EDTA). 
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2.2.1.2  Treatment of DNA with restriction endonucleases 
 
Cleavage of DNA was performed using restriction enzymes. Digestions were performed 
in a 1.5ml Eppendorf tube in a total volume of 20µl. Typically, 0.5- 1.0µg of DNA was 
digested in a buffer at a temperature according to manufactures instructions. The length 
of the digestion varied from 4 hrs to overnight. 
 
2.2.1.3  Running of agarose gels and purification of DNA fragments  
 
Separation of digested DNA products was performed by electrophoresis using agarose 
gels. The density of the gels used depended on the product length. DNA samples were 
prepared for loading by the addition of 10x loading dye (50% glycerol, 0.2M EDTA, pH 
8.3, 0.05% w\v Orange G and dH2O). To prepare agarose gel for electrophoresis, agarose 
and 1x TAE (0.04M Tris acetate, 0.001M EDTA) were mixed to a relevant concentration 
(typically 0.8 % to 1.5% w\v). The solution was heated in a microwave oven until boiling. 
It was allowed to cool to approximately 50°C and ethidium bromide was added. The 
solution was poured in a gel mold and allowed to set. At this stage it was placed in a gel 
tank (BioRad) containing 1x TAE buffer. Following loading, the samples were 
electrophoresed at 2-20V per cm. Subsequently, the DNA products were visualized in a 
UV trans-illuminator and the DNA fragments of interest were excised from the gel under 
UV light with a scalpel. The DNA product was then purified from the gel by use of the 
Nucleospin Extract II gel extraction kit (Macherey-Nagel). Concentrations of the purified 
products were determined by running alongside a 100bp ladder (NEB) of known 
concentration on an agarose gel. 
 
2.2.1.4  DNA ligation  
 
The ligation of DNA inserts into the plasmid vectors was carried out overnight at 16oC 
using 1 unit of T4 DNA ligase (Roche) and 1x ligase buffer. 
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2.2.1.5 Transformation of E. coli (Heat shock method) 
 
50µl of XL-1 blue competent cells were thawed on ice in an Eppendorf tube. 1-10ng of 
plasmid DNA was added to the tube and mixed gently by flicking the tube. The sample 
was then incubated on ice for 30 minutes. Cells were subjected to heat shock at 37oC for 
2 minutes and immediately chilled on ice for 30 seconds. Following chilling, 950µl of 
2xTY (liquid medium) was added to the cells and incubated for one hour at 37oC. Cells 
were then plated onto 2xTY-agar containing appropriate antibiotics. 
 
2.2.1.6  Growth and transformation of Agrobacterium tumefaciens 
 
The transformation technique in A. tumefaciens is related to E. coli in that the exponentially 
growing cells are stressed which leads to uptake of plasmid DNA added to that culture. 2ml 
O\N culture of Agrobacterium tumefaciens strain C58C1-pCV 2260 were used to inoculate 
100ml of Agrobacterium liquid medium (containing rifampicin and MgSO4) and 
incubated at 28°C for 4-5 hours (until O.D reaches 0.27). After pelleting the culture  
at 4°C , cells were resuspended in 1ml ice cold Agrobacterium medium. To the chilled 
200µl aliquot, 2-5µg of T-DNA vector was added and the culture was frozen in liquid 
nitrogen. Thereafter, cells were thawed (at RT), and incubated at 37°C (without shaking) for 5 
minutes. Following incubation, 1ml of Agrobacterium medium was added and the cells 
were incubated at 28°C (slight shaking) for two hours. Aliquots of these cells were then 
plated on selective medium and the plates were incubated at 28°C. Transformed colonies 
were visible on the plates after 2-3 days of incubation. 
 
2.2.1.7   Analysis of transformed A. tumefaciens 
 
             In order to find out whether the binary T- DNA vector is present in Agrobacterium, a 
plasmid DNA preparation was performed. 1.5ml of Agrobacterium culture grown under 
selective conditions were pelleted, resuspended in 150µl TE containing 0.5% (v\v) 
sarcosyl and proteinase K (100µg\ml), and incubated at 37°C for one hour. Afterwards, 
200µl alkaline\SDS solution was added and the Eppendorf tube kept on ice for 5 minutes.  
           After neutralization with 150µl acetate solution, the tube was kept on ice for additional 15 
minutes and thereafter centrifuged at 4°C for 15 minutes. The supernatant was transferred  
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            to a fresh tube and phenol: chloroform: isopropanol (PCI) extraction was performed. The 
DNA was then precipitated with 96% ethanol. The resulting pellet after centrifugation 
was washed with 70% ethanol, dried in a spin vacuum and resuspended in 30µl of H2O. 
One quarter of such DNA preparations was used for restriction digests. 10µg\ml of 
RNase A may be added to such digests. After one hour of incubation with restriction 
enzymes, the digested samples are ready to be analyzed on an agarose gel.  
 
2.2.1.8   A. tumefaciens mediated transformation of Arabidopsis thaliana 
 
Plants were transformed with Agrobacterium using a protocol based on floral dip method 
(Clough et al. 1998). 2ml of Agrobacterium culture (from 20 ml starter culture grown at 
28°C for 2 days) was used to inoculate 100ml of YEB medium containing appropriate 
antibiotics. Following an overnight incubation at 28°C with constant shaking, the cells 
were collected by centrifugation at 4000 rpm for 15 minutes at 4°C.  The cells were resuspended 
in 200ml of infiltration medium (5% sucrose and 0.05% silwet L-77). Plants were 
submerged in this solution for 2-3 minutes. Excess liquid was removed from the plants by 
allowing them to dry on their sides. Plants were then transferred to the greenhouse. A 
plastic sheet was used to cover the plants for 1-2 days to aid infiltration. 
 
2.2.1.9  Seed sterilization and selection of transformants 
 
Bleach sterilization 
 
Seeds (30-40) were taken in an Eppendorf tube and immersed in a solution containing 5% 
calcium hypochloride and 0.02% triton for 15 minutes with gentle shaking. The seeds 
were then rinsed 3 times with sterile water, dried in the fume hood and sprinkled onto the 
germination medium (GM) plates containing the appropriate selective agents. Following 
stratification (3-5days), the plates were placed into a long day percival cabinet or growth 
room. Plants that were not sensitive to the respective selective agent were removed from 
the plates after 15 days of growth, and transferred to soil. Following selfing and slique 
formation, the plants were bagged into seed collection bags, and allowed to dry out for 2- 
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3 weeks. Seed sterilization was repeated and segregation was analyzed by germinating 
seeds on GM medium with the appropriate selective agents. 
 
2.2.1.10  Crosses 
 
Following bolting and flower setting, some flowers from the female plant were 
emasculated by removal of petals, sepals and immature anthers with fine forceps. Pollen 
from a mature male plant was used to dust the exposed stigma. Following the cross, any 
new flowers and secondary stems growing in the proximity of the developing carpel were 
removed. Pollinated stigmas were wrapped in plastic foil for protection and to avoid 
additional pollination. 
 
2.2.1.11   Application of estradiol to transgenic Arabidopsis plants 
 
A 0.5µM solution of estradiol was sprayed on 45 day old plants (pER8 tag 3 SUMO1; 
estradiol inducible promoter) for induction of the SUMO1 protein. The plants were 
induced overnight with estradiol and harvested in the morning for biochemical 
enrichment of SUMO1 conjugates. 
 
2.2.2   Plant growth and analysis of flowering time 
 
Stratification and sowing 
 
Seeds were stratified on moist filter paper in the dark at 4°C for 3-5 days to break seed 
dormancy. Seeds were then sown on compost composed of, 7 parts peat: 2 parts vermiculite: 
1 part sand, fertilized with 1kg\m3 tribon and 1kg\m3 osmocote; supplemented with 12g\m3 
intercept (materials supplied by Blumenerdewerk Stender GmbH). Following sowing, the 
pots were covered with a plastic lid to maintain humidity. The covers were removed once 
the seeds germinated and had produced leaves. 
 
Light conditions  
Plants were grown either in the greenhouses or in controlled environmental chambers. 
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Greenhouses: Plants were grown in natural long days and short days. This was 
supplemented with artificial light in the winter to ensure a minimum day length of 15 
hours. Light could be blocked with rolling shutters during long summer days if short-day 
light conditions were required. 
 
Environmental chambers: Plants were grown in Percival controlled environment cabinets 
(Percival Scientific Inc., USA). For short day light conditions, cabinets were provided 
with 8 hrs of light. Long day light conditions comprised of 16 hrs of light.  
 
Measurement of flowering time 
 
Eight to ten plants per plant line were used to measure flowering time. The number of rosette 
and cauline leaves were counted before the first flower opened. Mean values from at least 
8 plants were calculated (Koornneef et al. 1991). 
 
2.2.3 Biochemical enrichment of SUMO1 conjugates from Arabidopsis  
 
SUMO1 conjugates were enriched from Arabidopsis plants overexpressing SUMO1 by 
the following two methods (Fig. 13) 
 
Method 1 
 
This method employed the use of Ni based immobilized metal affinity chromatography 
followed by further enrichment using anti-HA antibody coupled to a matrix in a batch 
procedure. 
 
Extraction buffer A: 6M Guanidinium chloride, 0.1M Na phosphate buffer, 0.1M Tris.Cl, pH 8 
 
Wash buffer B: 8M urea, 0.1M Na phosphate buffer, 0.1M Tris.Cl,  pH 8 
 
Elution buffer C: 8M urea, 0.2M acetic acid 
 
Dilution buffer D: 1% Triton, 0.1% SDS, 1mM β-Mercaptoethanol, Protease inhibitors 0.5-10µg\ml E64, 
0.1-1mg\ml Pefabloc, 0.7µg\ml Pepstatin 
 
 
200g of fresh transgenic plant material was ground in 5 volumes of buffer A. At the time of 
grinding, 20mM β-mercaptoethanol, 10mM sodium metabisulphite, 3-4% PVPP (poly  
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vinylpolypyrrolidone), 5% sucrose, and 5mM imidazole were added to the plant material. 
Grinding was done with a blender until the material blended well with the buffer into 
green homogenous slurry. Following grinding, the green slurry was stirred with a 
magnetic stirrer for 30 minutes and then centrifuged at 5000 rpm to collect the 
supernatant. The supernatant was collected by filtering through mira cloth and again 
centrifuged at 18,000 rpm for one hour. High speed centrifugation was done to pellet 
particulate matter which may interfere with affinity binding to the matrix. The 
supernatant was decanted carefully so as not to disturb the green material which settles as 
a loose pellet upon centrifugation. The resulting supernatant (free of particulate matter) 
was incubated with 8ml of Ni-NTA resin (50% slurry, Qiagen) on a rotating shaker overnight 
at RT (batch procedure). The following day, an empty chromatography column was 
packed with the overnight incubated Ni-NTA plant slurry. Subsequently, the column was 
washed with 5-10 column volumes of buffer B. The protein was eluted with 1-2 column 
volumes of elution buffer C. The eluted protein mixture was immediately neutralized 
with 1M Tris, pH 8 before proceeding to the next affinity purification step. In the cold 
room (8°C), the neutralized protein mixture was diluted 20 times with dilution buffer D, 
while stirring with a bar magnet and incubated overnight with 150-200µl of anti-HA 
affinity matrix (Roche) on a rotating shaker. An empty column was packed with the 
above protein mixture-anti HA matrix (cold room) and washed with dilution buffer D. 
Elution was done at 37°C for 15 minutes using 1-2ml of elution buffer C. The protein 
mixture was immediately neutralized upon elution with 1M Tris, pH 8.0. The eluted 
protein was concentrated with centrifugal device (Amicon) of 10,000 kDa molecular 
weigh cut off.  
 
Method 2 
 
This method involved the use of an immobilized metal affinity chromatography in two 
step procedure. Crude extracts were first enriched by Ni-NTA matrix followed by the use 
of Dyna beads to further fish out recombinant histidine tagged proteins. 
 
Binding and wash buffer: 8M urea, 0.1M Na phosphate buffer, 0.1M Tris.Cl, 0.01% Tween®- 20 pH 8 
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Elution buffer C: 8M urea, 0.2M acetic acid, 0.01% Tween®- 20 
 
The transgenic plant material was treated in a similar manner as described in method 1, 
until the protein mixture was eluted from the Ni-NTA column and neutralized with 1M 
Tris, pH 8.0. The next step in this method employed the use of Dyna beads® TALONTM 
(DYNAL Biotech), which are magnetizable beads developed for the isolation of 
recombinant histidine tagged proteins. Dyna beads were thoroughly resuspended prior to 
use. 50µl (2mg) of Dyna beads TALON solution was transferred to an Eppendorf tube. 
The tube was placed on a magnetic particle concentrator (DYNAL Biotec) until the beads 
had migrated to the side of the tube and the liquid was clear. The supernatant was 
discarded and beads were equilibrated with 700µl of binding and wash buffer. The sample 
was then added to the equilibrated beads and incubated on rotating shaker for 1 hour at 
RT (18-20°C). Thereafter, the supernatant was discarded upon separating the beads. The 
Dyna beads were washed four times with 700µl of binding and wash buffer, with through 
separation and resuspension between each washing step. The enriched protein mixture 
was eluted with 250µl of elution buffer upon incubating the suspension on a rotating 
wheel for 15 minutes at RT. The eluate was collected by separating the beads with a 
magnet. The protein mixture was immediately neutralized with 1M Tris, pH 8.0 upon 
elution and concentrated with Centricon centrifugal device prior to analysis.       
 
2.2.4     Techniques for protein analysis 
 
2.2.4.1  Isolation of proteins from A. thaliana 
 
A mini preparation technique was used to isolate proteins from A thaliana for Western 
blot analysis. A fresh leaf (~15mg) was frozen (with a pinch of sand) in liquid nitrogen. 
200µl of prewarmed (5 minute at 37°C) Fergusons solution (50mM Tris.Cl pH 6.8, 4% 
SDS, 10 % β-Mercaptoethanol) was added and the sample was ground with help of an 
electric homogenizer. Following grinding, the samples were briefly centrifuged (1minute, 
10,000 rpm) and the supernatant was transferred to a fresh Eppendorf tube. The 
supernatant was then heated at 95°C for 10 minutes and centrifuged at 14,000 rpm for 10 
minutes at RT. The supernatant after centrifugation contains the total protein extract from 
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the plant material and it can be used directly for SDS-PAGE after mixing with 2x LSB or 
stored at -80°C for later use. 
 
2.2.4.2   Measurement of protein concentration with Bradford reagent 
 
Protein concentration was measured using the ‘Bradford Protein Assay’. Bradford 
solution diluted 1:5 with water was filtered with a 0.45µm filter. 1ml of the filtered 
solution is added to varying amounts of aqueous protein solutions (50-100µl) in a test 
tube and incubated at RT. The colour of the solution changed from red to deep blue. 
OD595 was measured photometrically and the protein amount was estimated via a 
calibration curve of a standard protein (BSA). 
                                                         
2.2.4.3   Precipitation of proteins using organic solvents 
 
Organic solvents such as acetone and trichloroacetic acid (TCA) are useful for 
precipitating proteins and removing salts and detergents prior to protein analysis. Two 
volumes of 10% TCA in acetone was added to 1 volume of protein sample in an 
Eppendorf tube. The mixture was allowed to stand O\N at -20°C, followed by 
centrifugation of the mixture at maximum speed for 20 minutes. The supernatant was 
immediately decanted and the residual liquid was removed with a pipette. Residual traces 
of TCA were removed by washing the pellet with cold acetone. The protein pellet was 
dried on ice at RT. The precipitated protein was dissolved in 1x LSB and analyzed by 
SDS-PAGE. 
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     Plant material (~200g) 
 
                                             Grinding of plant material in extraction buffer A; 
                                 6M Guanidinium chloride, 0.1M NaP, 0.01M Tris buffer, pH 8.0 
                         PVPP, Sodium metabisulphite, β-mercaptoethanol, 5% sucrose, 5mM imidazole 
 
                                                            Centrifugation \ Filtration  
 
                                                   Ni-NTA column (batch procedure) O\N 
                                      
                                                                          Washings 
                 
                                                                            Elution 
                                                  8M urea and 0.2M acetic acid, Neutralization 
 
                                  
                Method 1                                                                                     Method 2 
 
Dilution of sample to 200mM urea with                                                     Equilibration of Dyna beads 
buffer containing : 1% Triton, 0.1% SDS, 
1mM β-Mercaptoethanol, protease inhibitors 
 
 
Incubation with anti-HA antibody matrix (batch procedure 4°C)            Incubation of sample with Dyna beads  
 
                 
                   Washings                                                                                               Washing        
                    
  
Elution 8M urea and 0.2 M acetic acid                              Elution 8M urea, 0.2 M acetic acid 0.01% Tween®- 20 
 
 
                              Neutralization followed by SDS-PAGE and Coomassie staining 
                       
                                     
Fig. 13 Schematic representation of the biochemical enrichment of SUMO1 conjugates   
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2.2.4.4 Sodium dodecylsulphate polyacrylamide gel eletrophoresis (SDS-PAGE) 
 
Mini gel and large gel  
 
Stacking gel (5%, 2ml): 1.4 ml dH2O, 0.33ml acrylamide-bis mix (29:1) 30% w\v (Serva), 0.25ml of 1.5M 
Tris pH 6.8, 0.02ml 10% SDS, 0.02ml of 10% ammonium persulphate, 0.002ml TEMED 
 
Resolving gel (15%, 5ml) : 1.1 ml dH2O, 2.5ml acrylamide-bis mix (29:1) 30% w\v (Serva), 1.3ml of 1.5M 
Tris pH 8.8, 0.05ml 10%SDS, 0.05ml of 10% ammonium persulphate, 0.002ml TEMED 
 
2x (LSB): 50% glycerol, 20mM DTT (Dithiothreitol), 2% SDS, 125mM Tris. Cl pH 6.8, 0.03% 
bromophenol blue 
 
2x (LSB) – non-reducing gel. All of above except DTT 
 
5x electrophoresis buffer: 25mM Tris, 192mM Glycine, 0.5% SDS v\v 
 
 
Proteins were separated on 10-15% SDS-polyacrylamide gels. Samples were incubated in 
the same volume of 2x Laemmli-sample buffer (LSB) at 65o C then loaded into the wells. 
For non-reducing gels, 2x Laemmli-sample buffer without the reducing agent (DTT) was 
used. Wells without the sample were filled with 1x LSB. This reduces ‘gel smiling’ and 
provides a better running gel front. The stacking gel concentration used was 5%. 
Electrophoresis was performed at 70 V in the stacking region and at 100V (constant 
voltage) in the resolving gel with 1x electrophoresis buffer. Mini gel apparatus used was 
from BioRad and for large gels an apparatus was procured from Whatman Biometra. 
 
Invitrogen mini gel apparatus 
 
For some experiments, NuPAGE precast 4-12% bis tris gels were used. The samples 
were incubated with the loading buffer provided with the system according to the 
suppliers instructions. Running buffer for the electrophoresis was also prepared according 
to the suppliers instructions.  Electrophoresis was done at 200V (constant voltage). 
 
2.2.4.5  Coomassie staining of proteins resolved by SDS-PAGE 
 
Gels that were not used for Western blotting were stained with Coomassie stain. Roti-
Blue (Roth), a commercial name of a colloidal Coomassie stain was used for staining the  
protein gels. A solution (60% water, 20% Roti-Blue, 20% methanol) was prepared for 
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staining the gels for minimum of 7-8 hours. The gels stained with this specific Coomassie 
stain (Roti-Blue) do not require destaining. The protein bands are stained blue in a 
transparent background. 
  
2.2.4.6   Sypro-Ruby staining of proteins 
 
After electrophoresis, the gels were incubated in the fixative solution (10% methanol,7% 
acetic acid) at RT for 15 minutes. The fixation step was repeated. Following fixation, 
50ml of Sypro-Ruby stain (Molecular probes) was used for staining the gels overnight. 
Thereafter, to reduce background fluorescence and increase sensitivity, the gels were 
transferred to a clean staining dish and washed two times in 10% methanol, 7% acetic 
acid for 30 minutes. The gel was then monitored using UV-illumination and treated for 
mass spectrometry analysis. 
 
2.2.4.7   Excision of protein bands, in-gel trypsin digest, and MALDI-TOF analysis 
 
Excision of protein bands from polyacrylamide gel and washing 
 
The stained gel was washed for 10 minutes with water (gentle shaking). Stained protein 
bands (Coomassie stain) of interest were excised, cut to 1 mm-cubes with a sharp knife 
and transferred to a 0.5µl Eppendorf tube. The gel pieces were then washed with water, 
followed by a wash with 50mM NH4HCO3\acetonitrile 1:1 (v\v) for 15 minutes. All the 
liquid was removed and the gel pieces were covered with acetonitrile until the gel shrunk 
and shriveled together. Acetonitrile was removed and the gel was rehydrated in 50mM 
NH4HCO3. After 5 minutes of incubation, an equal volume of acetonitrile was added. All 
the liquid was removed after 15 minutes. Again acetonitrile was added and removed from 
the Eppendorf tube after the gel pieces had contracted. The gel pieces were then dried in 
a vacuum centrifuge. 
 
Reduction and alkylation 
 
To the dried gel pieces, 10mM DTT\25mM NH4HCO3 (freshly prepared) was added and 
the sample was incubated for 45 minutes at 65°C. After incubation, the Eppendorf tubes  
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were chilled to RT, the liquid was removed and replaced quickly by the same volume 
(enough to cover the gel pieces) of freshly prepared 55mM iodoacetamide (light 
sensitive) in 25mM NH4HCO3. The tubes were incubated for 30 minutes at RT in dark.  
The iodoacetamide solution was removed and the gel pieces were washed with in 50mM 
NH4HCO3 \acetronitrile 1:1 (v\v) for 15minutes. The washing step was repeated twice. 
The gel pieces were again covered with acetonitrile and after the gel shrunk, liquid was 
removed and the gel pieces were dried in a vacuum centrifuge.  
 
In-gel  trypsin digest 
 
To the dried gel pieces, freshly prepared enzyme solution (25mM NH4HCO3 with 5ng\µl 
of trypsin) was added to cover the gel, which was incubated at 37°C for 30 minutes. The 
gel pieces soak up the enzyme solution. Enough 25mM NH4HCO3 was added to keep the 
gel wet before O\N incubation at 37°C.  
 
Extraction of peptides 
 
The gel pieces were sonicated for 10 minutes and the supernatant was recovered. A 
solution of 50% acetonitrile and 1% trifluoracetic acid was added to the gel pieces, which 
were sonicated again for 10 minutes. The supernatant was recovered after sonication and 
the extraction step with acetonitrile\trifluoacetic acid was repeated. The supernatant was 
pooled and concentrated to about 10µl in a vacuum centrifuge.  
 
Zip-Tip purification  
 
Zip-Tip (C18, tip size P10, Millipore) was used for purification of the sample before 
analysis by MALDI-TOF. The Zip-Tip was washed twice with 10µl of 50% acetonitrile 
and 0.1% trifluoracetic acid. Thereafter, the tip was equilibrated twice with 10µl of 0.1% 
trifluoracetic acid.  Peptide binding was done by pipetting the solution 3-10 times through 
the filter matrix. The tip was then washed four times with 10µl of 0.1% trifluoracetic acid. 
Finally, the peptides were eluted with 8µl of 50% acetonitrile and 0.1% trifluoracetic acid. 
 
 
 
 
           
   Material and methods 
 44
 
 
MALDI-TOF 
 
The peptides were analyzed by MALDI-TOF mass spectrometry (Bruker Daltonics, 
Reflex IV). Protein identification and result assessment was done with data base system 
(NCBI) using MASCOT (Matrix science) and Profound (Genomic solutions) search 
engines. 
 
2.2.4.8  Isoelectric focusing (IEF)   
 
Isoelectric focusing was done with ZOOM IPGRunner System (Invitrogen life 
technologies)  
 
Rehydration of ZOOM strips:  
 
Rehydration buffer: 7M Urea, 2M Thiourea, 25mM CHAPS, 0.5 %(v\v) Ampholyte pH 3-7, 0.002% 
Bromophenol blue, 20µl DDT 
 
Precipitated protein samples (Protein samples were precipitated as described in section 2.2.4.3) 
were resuspended in 150µl of rehydration buffer. The  rehydration buffer containing the 
protein sample was loaded into the sample loading well in the ZOOM IPGRunner 
cassette. The protective covering from the IPG strip was peeled off. Each IPG strip has a 
gel side and a side with printed marking on it. The strip with the gel side upwards and 
held with forceps on the basic (-) end was gently slid through the sample loading well of 
the ZOOM IPGRunner cassette. The IPG strip was inserted until the acidic (+) end of the 
strip touched the end of the channel slot. Care was taken to avoid introducing large air 
bubbles while sliding the IPG strip into the sample well. All sample loading wells in the  
IPGRunner cassette were sealed with a sealing tape provided with the kit. This was done 
to create a sealed environment for rehydration. The ZOOM IPGRunner cassette with the 
ZOOM strips was incubated for 8-16 hours at RT to hydrate the strips.  
 
Focusing 
 
The sealing tape was removed from the ZOOM IPGRunner cassette. Electrode wicks 
(provided with the kit) were moistened with deionized water and placed over the exposed  
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adhesives at each end of the ZOOM IPGRunner cassette. The IPGRunner apparatus was 
then assembled by sliding the ZOOM IPGRunner cassette towards the electrodes of the 
ZOOM IPGRunner core until the electrode wicks of the ZOOM IPGRunner cassette are 
in contact with the electrodes of the ZOOM IPGRunner core. The gel tension lever which 
holds the ZOOM IPGRunner cassette and ZOOM IGRunner core firmly, was inserted 
into the focusing chamber. The outer chamber of the focusing apparatus was filled with 
600ml of deionized water and isoelectric focusing was performed (Voltage ramp: 175V 
for 15 minutes, 175-2000V ramp for 45 minutes, and 2000V for 20-30 minutes). 
Following isoelectric focusing, the entire cassette with the strips can be stored in a sealed 
container at -80°C or the IPG strips can be removed from the cassette and stored (in a 
sealed container) at -80°C for later follow up experiment.   
 
Equilibration of IPG strips 
 
Equilibrating the ZOOM IPG strips in the equilibration buffer prepares the strips for 2D 
SDS-PAGE. 
 
Equilibration buffer A: 4.5ml 1x NuPAGE LDS sample buffer, 0.5ml NuPAGE sample reducing agent 
 
Equilibration buffer B: 4.5ml 1x NuPAGE LDS sample buffer, 116mg iodoacetamide 
 
 
Each IPG strip was incubated in a conical tube containing equilibration buffer A for 15 
minutes at RT. After 15 minutes of incubation equilibration buffer A was decanted, 
equilibration buffer B was added to the tube and the strip incubated further for 15 
minutes. The strips were ready to proceed for SDS-PAGE. 
 
2.2.4.9  Two-dimensional gel electrophoresis 
 
A 0.5% agarose solution was prepared and kept warm (55-65°C) until use. The ZOOM 
IPG gel cassette was disassembled and the IPG strips were gently removed. The plastic 
ends of the strip were cut off, taking care not to cut any gel pieces. The IPG strip was slid 
into the channel well of a precast 4-12% bis-tris gel using a thin spatula or a thin plastic 
ruler. 400µl of 0.5% agarose solution was added to the well containing the IPG strip,  
 
           
   Material and methods 
 46
 
taking care that the agarose did not flow into the well containing the molecular weight 
marker. The agarose was allowed to solidify. A typical SDS-PAGE was performed using 
the Invitrogen mini eletrophoresis apparatus according to the supplier’s instructions.  
 
2.2.4.10  Protein spotting, trypsin digests with a robot and MALDI-TOF analysis 
 
Samples subjected to two-dimensional gel electrophoresis were subsequently stained 
using Sypro-Ruby according to the producer’s manual (Molecular probes). Fluorescence 
images were acquired using FLA 3000 (Fuji film). Spots of various intensities were 
automatically picked (PROTEINEER sp, Bruker) and tryptically digested with a robot 
(PROTEINEER dp, Bruker). Aliquots of the digest were prepared for MALDI-TOF\MS. 
Aliquots of more interesting spots were subjected to LC-MS\MS analysis. Protein 
identification and result assessment was done on a protein scape 1.3 database system that 
triggered Mascot searches (MATRIX sciences) and simplified the evaluation of MS and 
LC\MS searches in a gel related context using Bio-Tools 3.0 (Bruker). 
 
2.2.4.11 Western blotting 
 
Transfer buffer: 190mM glycine, 20mM Tris, 20% methanol, 0.05% SDS 
 
1x ANT: 150mM NaCl, 50mM Tris.Cl pH 8, 0.02% sodium azide (NaN3) 
 
NBT( Nitoblue Tetrazolium chloride) solution. 110mM in 70% 
dimethylformamide(DMF) solution  
 
X-phosphate solution: BCIP (5- Bromo-4 chloro 3-indolephosphate) 90mM in DMF 
 
After eletrophoresis, gels were transferred to a trough containing transfer buffer and 
equilibriated for 30 minutes with gentle shaking.  Meantime, a piece of PVDF-membrane  
(Millipore) was briefly dipped in methanol and also equilibriated in transfer buffer. The 
transfer was performed in the BioRad transfer apparatus for one hour at 50V (constant 
voltage) in the cold room. Subsequent to the transfer, the membrane was blocked for 1.5 
hours with 20% NCS at room temperature. Following blocking, the blot was incubated 
with the primary antibody diluted to a final concentration of 1:1000 in the 20%  
NCS\1xANT. Incubation with the primary antibody was done O\N in the cold room. 
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After washing the membrane with 1xANT containing 0.05% Tween 20, (4 washes, 15 
minutes each) a secondary antibody conjugated to alkaline phosphatase (1:1000) in 20% 
NCS\1xANT was added and the blot was incubated at RT for 2 hours. After several 
washing steps (3 times, 10 minutes each) with 1xANT\0.05% Tween 20, the membrane was 
developed in dark with TE containing 45µl\10ml of NBT solution and 35µl\10ml of X- 
phosphate solution (BCIP). 
 
2.2.4.12  Small scale testing of overexpression of proteins in E. coli 
 
IPTG: (Isopropylthiogalactoside) stock solution 100mM, filter sterilized 
 
To find out whether recombinant expression vectors express the cloned gene properly, a 
small scale protein preparation was carried out. 4ml of 2xTY medium containing the 
appropriate antibiotic was inoculated with 400µl of an O\N culture and grown at 37°C to 
an OD600 of 0.8. 1mM IPTG was added and the culture was further incubated for 3-4 
hours. 100µl of the culture was pelleted by centrifugation and suspended in 10µl of dH2O 
and 10µl of 2x LSB. The resuspended cultures were boiled at 95°C for 10 minutes before 
use for SDS-PAGE. 
 
2.2.4.13  Purification of His-tagged proteins expressed in E. coli using Ni-NTA matrix 
 
Native conditions 
 
Lysis buffer (1 litre): 50mM NaH2PO4, 300mM NaCl, 10mM imidazole, pH 8 
 
Wash buffer (1 litre): 50mM NaH2PO4, 300mM NaCl, 20mM imidazole, pH 8 
 
Elution buffer (1 litre): 50mM NaH2PO4, 300mM NaCl, 250mM imidazole, pH 8 
 
Overexpression of proteins fused to a His tag allows purification using a Ni-NTA matrix. 
E. coli cells containing the fusion vector were grown at 37°C O\N in 10ml of culture 
medium containing selective antibiotics. 100ml of prewarmed medium (with antibiotics) 
was inoculated with 5ml of the overnight culture and grown at 37°C with vigorous 
shaking until an OD600 of 0.7 was attained. 1mM of IPTG was added to induce the 
expression of the gene. After 4-5 hours of growth, cells were harvested by centrifugation  
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at 5000 rpm for 20 minutes. The pellet was stored at -20°C until use. The frozen cell 
pellet was thawed on ice and the cells were resuspended in lysis buffer at 2-5ml per gram 
wet weight. 1mg\ml lysozyme was added and the resuspended cells were incubated on ice 
for 30 minutes.  The partially disrupted cells were then sonicated on ice (six 10 second 
bursts at 200-300W with 10 seconds cooling period after each burst) using a sonicator 
equipped with a microtip. The lysate was centrifuged at 10,000 x g for 20-30 minutes at 
4°C to pellet the cellular debris. Thereafter, the supernatant (cleared lysate) was removed.  
1ml of the 50% Ni-NTA slurry was added to 4ml cleared lysate and mixed gently by 
shaking at 4°C for 1 hour on a rotating shaker. The lysate Ni-NTA mixture was loaded 
into a column and the column flow through was collected for analysis. The column was 
washed twice with 4ml wash buffer, and fractions were collected. Thereafter, the protein 
was eluted 5-6 times with 0.5ml of elution buffer. Fractions of the eluate were collected 
in different tubes and analyzed by SDS-PAGE. Subsequent to SDS-PAGE analysis, the 
fractions of interest were further purified by sizing chromatography. FPLC was done 
using a superdex 200 column and the whole procedure was performed using an automated 
FPLC system (Amersham). The samples were centrifuged at maximum speed, or filtered 
through a 0.2µm filter before injecting into the FPLC system.  
 
Denaturing conditions 
 
Lysis buffer (1 litre): 100mM NaH2PO4, 10mM Tris.Cl, 6M Guanidinium chloride, pH 8 
 
Wash buffer (1 litre): 100mM NaH2PO4, 10mM Tris.Cl, 8M Urea, pH 6.3 
 
Elution buffer (1 litre): 100mM NaH2PO4, 10mM Tris.Cl, 8M Urea, pH 4.5 
E. coli cells containing the fusion vector were grown in 10ml of culture medium 
containing the selective antibiotics at 37°C O\N. 100ml of prewarmed medium (with antibiotics) 
was inoculated with 5ml of the overnight cultures and grown at 37°C with vigorous 
shaking until an OD600 of 0.7 was attained. 1mM of IPTG was added to induce the 
expression of the gene. After 4-5 hours of growth, cells were harvested by centrifugation 
at 5000 rpm for 20 minutes. The pellets were stored at -20°C until use. The frozen cell 
pellet was thawed on ice and the cells were resuspended in lysis buffer at 5ml per gram  
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wet weight. Cells were stirred at room temperature in the lysis buffer or alternatively 
lysed by gentle shaking with a vortex mixture, taking care to avoid foaming. The lysate 
was centrifuged at 10,000xg for 20-30 minutes at 4°C to pellet the cellular debris. 
Thereafter, the supernatant was decanted. 1ml of the 50% Ni-NTA slurry was added to 
4ml cleared lysate and mixed gently for 1 hour (RT) on a rotating shaker. The lysate - Ni-
NTA mixture was loaded into an empty column and the column flow through was 
collected. The column was washed twice with 4ml wash buffer, and fractions were 
collected. Thereafter, the protein was eluted 5-6 times with 0.5ml of elution buffer. 
Fractions of the eluate were collected in different tubes and analyzed by SDS-PAGE. 
 
2.2.4.14   Expression and purification of SUMO-conjugating enzyme (SCE) 
 
This experimental procedure was courtesy of Dr. Frauke Melchior (MPI, Martinsried\Univ. of 
Göttingen). The SUMO-conjugating enzyme gene cloned in an expression vector (pET-
9d) was transformed in BL21(DE3) competent cells. From a 50ml O\N culture, 20ml of 
culture was withdrawn. The cells were harvested by centrifugation, reuspended in 20 ml 
fresh medium and the culture was used for inoculating 2 liters of 2xTY selective 
(antibiotic) medium. The cells grown at 37°C were induced with 1mM IPTG after an 
OD600 of 0.7 was attained. The culture was further incubated for 3-4 hours at 37°C. 
Bacteria were harvested by centrifugation and resuspended in 60ml buffer containing 
50mM Na-phosphate buffer pH 6.5 and 50mM NaCl. The resuspended bacteria were 
stored at -80°C overnight (freezing is essential). Cells were thawn on ice and 
subsequently 1µg\ml protease inhibitors (PMSF, aprotinin, leupeptin, pepstatin) and 
1mM DTT were added to the thawed cells. Thereafter, ultracentrifugation was done at 
100,000xg for 1 hour at 4°C. 10ml SP-Sepharose beads (SIGMA) were equilibrated by 
resuspension and centrifugation as follows: 1x with 0.5M Na-Phosphate (pH 6.5); 2x with 
0.5M Na-Phosphate, 50mM NaCl (pH 6.5) and 1x with 0.5M Na-Phosphate, 50mM NaCl 
(pH 6.5), protease inhibitors and 1mM DTT. The bead suspension was loaded onto a 
50ml empty column (cold room). The supernatant from the ultracentrifugation was 
passed through the packed column (discarded flow through). Subsequently, the column 
was washed with 2-3 bed volumes of 0.5M Na-Phosphate, 50mM NaCl (pH 6.5), 
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protease inhibitors and 1mM DTT. Protein was eluted with 2-3 column volumes of buffer 
consisting of 0.5M Na-Phosphate, 300mM NaCl (pH 6.5), protease inhibitors and 1mM 
DTT. Eluate was collected in 2ml fractions and kept on ice. The fractions were analyzed 
by SDS-PAGE and stained with Coomassie colloidal stain. The peak fractions were 
pooled and concentrated to a volume of 1-2ml with a Centricon centrifugal device. The 
sample was filtered through 0.2µm filter or centrifuged at maximum speed before loading 
on to a preparative Superdex 200 column (FPLC). The column was equilibrated with 
buffer containing 20mM Hepes\KOH (pH 7.3), 110mM potassium acetate, 2mM 
magnesium acetate, 0.5mM EDTA, 1mM DDT, 1µg\ml aprotinin, 1µg\ml each of 
leupeptin and pepstatin prior to sample loading. The eluate was collected in 5 ml 
fractions. The fractions were analyzed by SDS-PAGE and the gel was Coommasie 
stained. The peak fractions were pooled, and small aliquots (15-30µl) were flash frozen 
in liquid nitrogen.  
 
2.2.5   Production of SCE antibody in rabbit 
 
The SUMO-conjugating enzyme used for antibody production was purified using Ni- 
NTA resin under denaturing conditions. The concentration of the protein was determined 
using Bradford assay. A SDS-PAGE was performed and the gel was stained with 4M 
sodium acetate solution for 2-3 hours. The protein band was excised from the gel and 
send to Eurogentec (Belgium) for SCE antibody production. 400mg of the protein per 
rabbit was send to the company. Two rabbits were injected for antibody production. 
 
2.2.5.1  Purification of rabbit polyclonal immunoglobulins (IgGs) using affinity  
             chromatography 
 
Two thirds of the final bleed obtained from the company Eurogentec was used for purification 
of the SCE antibody from crude serum using affinity chromatography. 
 
Ammonium sulphate precipitation  
 
The crude serum was mixed with 1 volume of phosphate buffered saline (PBS), pH 7.4.  
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The mixture was gently stirred on ice and simultaneously solid ammonium sulphate was 
added (29.1g\100ml). This preparation was kept at 4°C O\N. The following day, the 
mixture was centrifuged at 8000rpm at 4°C for 15 minutes and the supernatant was 
discarded. The pellet was dissolved in 20ml of PBS and dialysed in a dialysis tubing 
(molecular weight cut off 12000-14000 kDa, Serva) in the cold room. PBS, pH 7.4 was 
used as dialysis buffer.  
 
Ligand coupling and binding of precipitated serum proteins 
 
A 2ml uniform suspension of Affi gel 10 was equilibrated by suspension and 
centrifugation in 5mM HEPES, 20mM NaCl pH 7.5. 25mg\ml of ligand (purified SCE) 
was added, and the matrix was gently agitated on a rotating shaker at 4°C O\N. 
Thereafter, 0.1ml of 1M ethanolamine HCl was added per ml of the gel matrix. The 
ligand coupled matrix was then loaded onto a 20ml empty chromatography column and 
equilibrated with PBS. Precipitated serum proteins (dissolved in 20ml PBS) were applied 
to the column and the flow through was collected. The flow through was passed through 
the matrix in the column and subsequently the column was washed with 3-4 bed volumes 
of PBS buffer. Immunoglobulins were eluted with 20ml 0.1M glycine.HCl (pH 3.0) in 
2ml fractions, which were immediately neutralized with 1M Tris, pH 8 and analyzed by 
SDS-PAGE. 
 
2.2.6  In vitro sumoylation assays   
 
The in vitro SUMO conjugation system employed in this investigation contains human 
SAE (0.5µg of SAE1/SAE2, Biomol or Boston Biochem), human SCE (1µg Ubc9),  
Arabidopsis SUMO proteins (1µg) and substrate protein (2-5µg) in sumoylation buffer 
(20mM Tris PH 7.5, 5mM MgCl2, 5mM ATP). The assays were performed in 50µl 
volume. The sumoylation reactions were incubated at 30°C for 4 hours. Reactions were 
terminated by boiling the mixture in SDS containing loading buffer. Reaction products 
were separated on a 12% SDS-PAGE and Western blotting was done using an antibody 
specific to the epitope tag on the substrate. 
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2.2.7    Brief protocol for PCR-grade DNA isolation from A. thaliana.  
 
30-50 mg of plant material (leaves) was homogenized in 400µl buffer (200mM Tris pH 
7.5, 250mM NaCl, 0.5% SDS, 25mM EDTA) with an electric homogenizer (IKA Ultra 
Turrax, Germany). Cell debris was removed by centrifugation (5 minutes, 14,000 rpm, 
RT). The supernatant was transferred to a fresh Eppendorf tube, mixed with 1 volume 
isopropanol and incubated at RT for 5-10 minutes. Precipitated nucleic acids were 
collected by centrifugation (5 minutes, 14,000 rpm, RT), washed with 70% ethanol and 
dried in a spin vacuum. The pellet was resuspended in 50µl TE buffer by incubating at 
65°C for 10 minutes. 1-3µl of the crude DNA preparation was used in a 50µl PCR 
reaction. 
 
2.2.8    Polymerase chain reaction (PCR) 
 
PCR reactions were typically carried out in 50 µl reactions. For standard PCR, DNA was 
amplified by the use of Taq DNA polymerase. Typically, a PCR mixture employed 1.25 
units Polymerase, 0.4µM  forward (Fwd) and reverse (Rev) primers, 200µM dNTPs 
(dATP, dCTP, dGTP, dTTP) and 1x PCR buffer (10x PCR buffer: 100mM Tris.Cl pH 8.3, 
500mM KCl, 15mM MgCl2, 0.1% gelatin, 0.5% Tween 20, 250µg\ml BSA). The 
temperature regime consisted of an initial 2 minute denaturing step at 96°C. This was 
followed by a cycle of denaturing, annealing and extension conditions. The number of 
cycles and the temperatures of each step depended on template and primers. A typical 
PCR had 30 cycles of (i) 30 seconds denaturing at 94°C (ii) 30 seconds annealing at 62°C 
(iii) 2 minute extension at 72°C. This cycling was followed by a 10 minute final 
extension. The major variations in PCR conditions involved differences in the number of 
cycles performed and the use of different annealing temperatures. 
 
 2.2.9    Nucleic acid hybridization techniques 
 
 2.2.9.1  Isolation of total RNA from A. thaliana 
 
RNA extraction was performed using the Qiagen RNeasy plant mini kit extraction. 100 
mg of the plant tissue was ground with a pestle and mortar to homogenize the tissue, and  
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450µl of lysis buffer RLT was added. The sample was mixed on a vortex shaker and 
incubated at RT for two minutes. It was then added to a QIAshredder spin column and 
centrifuged for 2 minutes at maximum speed. The supernatant was removed and added to 
225µl of 100% ethanol. The sample was added to an RNeasy minicolumn and centrifuged 
for 15 seconds at 1000 rpm (Eppendorf microcentrifuge). 700µl of wash buffer RW1 was 
added to the column, and the column was centrifuged for 15 seconds at 1000 rpm. The 
column was transferred to a new collection tube, and 500µl of wash buffer RPE were 
added. The sample was centrifuged for 15 seconds at 10,000 rpm. The RPE wash step 
was repeated. The column was transferred to a new 1.5ml collection tube and RNA was 
eluted by the addition of 50µl of RNase free water to the column, followed by 
centrifuging for one minute at 10,000 rpm. Concentration of RNA was analysed by 
running an agarose gel and comparing the intensity of the RNA bands to a standard RNA 
marker. 
 
2.2.9.2 Electrophoresis of RNA on denaturing gels 
 
10x MOPS (1L): 41.8 g MOPS, 16.6ml of 3M NaOAc, 20ml of 0.5M EDTA, H2O upto 1000 ml, store the 
solution in dark. 
 
6x RNA loading buffer: 150mg Ficoll, 200µl of 0.25 EDTA, 0.15% w\v orange G 
 
RNA sample buffer (24µl each sample): 2.4µl 10x MOPS, 4.5µl formaldehyde, 12µl deionized formamide, 
4.5µl DEPC-H2O, 0.75µl of 6x RNA loading buffer, 0.75µl ethidium bromide (7mg\ml) 
 
 
RNA was fractionated by running through a 1.2% agarose, 3% formaldehyde gel (115 ml 
gel = 1.40g agarose, 3.5ml formaldehyde, 11.16ml 10x MOPS, 100ml DEOPC treated 
water; MOPS and formaldehyde were added after the dissolved agarose had cooled to 
65°C). 5-10µg of RNA was precipitated with 3M DEPC-NaOAc and 96% ethanol. The 
RNA pellet was then suspended in 24µl RNA sample buffer. Prior to loading, the samples 
were heated for 5 minutes to 95°C and then briefly centrifuged at 4°C. Electrophoresis 
was performed at 5V\cm gel in a fume hood. Electrophoresis buffer was 1x MOPS. 
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2.2.9.3 Northern blotting 
 
20x SSC: 3M NaCl, 0.3M Sodium citrate, pH 7 
 
Following electrophoresis, the formaldehyde\agarose gel was placed in a tray containing 
water and gently shaken. This was followed by two 15 minute rinses in 10x SSC. The gel 
was placed on two pieces of Whatman 3MM paper, supported over a reservoir of 20xSSC. 
The ends of the Whatman 3MM paper were submerged in the 20xSSC solution to form a 
wick. A piece of nylon membrane (Hybond-N, Amersham) was cut to the same size as 
the gel, and dipped in 50% DEPC-methanol, rinsed in DEPC-water and subsequently in 
10xSSC. The membrane was placed on top of the gel, and any air bubbles present were 
removed by rolling with a glass pipette. Three more pieces of Whatman 3MM paper were 
cut to the size of the gel, presoaked in 10xSSC and placed on top of the nylon membrane. 
A stack of paper towels was then placed on top and a ~500g weight was placed on the 
towels. This encouraged the transfer of the 20xSSC from the reservoir to the paper towels, 
through a capillary action. The setup was left overnight, to allow the RNA to thoroughly 
transfer to the membrane. After the transfer, RNA was bound to the membrane by UV 
cross linking (12000µJ UV light, Stratagene Stratalinker) followed by baking for 2 hours 
at 80°C.  
 
2.2.9.4 Radioactive labeling of probes 
 
60-90 ng of probe DNA was denatured by boiling in an appropriate amount of distilled 
water (for the total reaction volume of 30µl). The denatured probe was immediately 
transferred to ice in order to retain its denatured state. 3µl of hexadeoxyribonucleotides 
(10x, Roche) and 3µl of 5mM dNTP (without dCTP) were added to the denatured probe 
on ice. Further, 4µl (~40µ Ci) of radioactivity [α- 32P] was then added to the probe DNA 
followed by addition of 1µl Klenow fragment (2 units\µl). The reaction was incubated for  
1 hour at 37°C. To remove the unincorporated nucleotides from the probe, the probe was 
purified with a Nucleospin-Extract II gel extraction kit (Machinery-Nagel) according to 
the supplier’s instructions. The purified probe was eluted with 50µl of elution buffer 
supplied in the kit. A further 50µl of TE was added to the eluted probe. The probe was  
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then denatured by boiling in an Eppendorf tube for 5 minutes and transferred 
immediately to ice. 
 
2.2.9.5 Hybridization of radio labeled probe to RNA immobilized on nylon 
membrane. 
 
Hybridization buffer: 1% BSA, 1mM EDTA, 0.5M sodium phosphate buffer pH 7.2, 7% SDS 
Wash buffer A: 2x SSC, 0.1% SDS 
Wash buffer B: 1x SSC, 0.1% SDS 
Wash buffer C: 0.5x SSC, 0.1% SDS 
Wash buffer D: 0.1x SSC, 0.1% SDS 
 
The nylon membrane was pre-hybridized at 65°C for one hour in Pyrex glass tubes 
containing 20-25ml of the hybridization buffer. This was performed in a hybridization 
oven containing a rotating spindle. Radiolabelled denatured probe was then added to the 
Pyrex tube, and returned to the oven. Hybridization was performed overnight. Thereafter, 
the membrane was rinsed with low stringency wash buffer A, and then washed for 40 
minutes. This wash was followed by another wash of 25 minutes with high stringency 
buffer B (25ml), then 15 minutes with buffer C in the oven. The final wash was with a 
high stringency buffer D for 3-5 minutes. Following washing, membranes were sealed in 
a cling film. The strength of the hybridization signal was assessed with a Giga counter. 
Thereafter, the membrane was exposed to the screen of a phosphoimager cassette. For re-
use, the membrane was stripped to remove the probe by subjecting it to two washes of 2-
3 hours in boiling 0.1% SDS solution. 
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3. RESULTS 
 
3.1     Characterization of proteins of the sumoylation pathway 
 
3.1.1   Cloning and expression of tagged SUMO isoforms in pET-9d 
 
SUMO isoforms, SUMO 1, 3, 5, 6, 7, 7v (see table 4; sequences in appendix) were first 
tagged with three affinity purification tags, namely Strep tag, triple hemagglutinin 
affinity tag and octahistidine Ni affinity sequence at the amino terminus of each gene. 
The pBluescript vector carrying the sequences for the expression of these tags was 
cleaved with Asp718 and XbaI. Inserts of SUMO1, 3, 5, 7 and 7v (Asp718 and XbaI) 
were then ligated into the linearized pBluescript plasmid containing the tags, which 
generated the SUMOs with three affinity tags. The resulting plasmid was called pSK tag3 
SUMO insert. To obtain the inserts of SUMO isoforms with the affinity tags, SUMO1, 3, 
7 and 7v were cleaved with NotI, the recessed ends were filled in with Klenow enzyme 
and finally digested with NcoI. For SUMO5 and SUMO6, Ecl136II and NcoI were used 
for cleavage. The pET-9d expression vector was cleaved with BamHI, followed by 
Klenow fill in and cleavage with NcoI. Tagged SUMO inserts (1, 3, 5, 7, 7v) were ligated 
into the linearized pET-9d vector and transformed into E. coli (XL1- Blue). The clones 
obtained were screened for the respective SUMO inserts. The correct clones were used 
for recombinant DNA isolation and the isolated DNA construct was transformed into E. 
coli (BL 21) cells for expression studies.  
Small scale cultures of SUMO1, 3, 5, 6, 7 and 7v were used for the preparation of crude 
protein extract and subjected to SDS-PAGE. Most of the overexpressed SUMOs except 
SUMO6 were visible as a prominent band corresponding to their expected molecular 
weight (Fig. 14) in the Coomassie stained gel. 
 
3.1.2 Purification of SUMO isoforms from E. coli 
 
SUMO isoforms were purified under native conditions using 100ml of pET-9d tag 3 
SUMO (1, 3, 5, 6, 7 and 7v) cultures grown and induced as described in section 2.2.4.13. 
Purification of the overexpressed protein was performed by metal affinity 
chromatography (Ni-NTA) according to the protocol described in The QIAexpressionist,  
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5th edition (for detailed description see material and methods). The Ni-NTA purified 
fraction of the proteins was subjected to size exclusion chromatography (FPLC) using 
superdex 200 column. Fig.15 shows the purified fractions of the various SUMOs on a 
Coomassie stained gel. The results indicate that all Arabidopsis SUMO proteins were 
stably expressed and purified from E. coli.  
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Fig. 14 SDS-PAGE analysis of cell 
lysates from SUMO expressing E. coli
clones. Lane 1 represents: Protein marker, 
lane 2: non induced SUMO1 expression, 
lane 3: IPTG induced expression of 
SUMO1, lane 4: IPTG induced expression 
of SUMO3, lane 5: non induced SUMO5 
expression, lane 6: IPTG induced 
expression of SUMO5, lane 7: IPTG
induced expression of SUMO6, lane 8: 
IPTG induced expression of SUMO7, lane 
9: IPTG induced expression of SUMO7v. 
The gel was stained with Coomassie blue 
for visualization of protein bands. Red 
arrows indicate the various SUMO 
protein bands.  
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Fig. 15 Purification of recombinant 
SUMO proteins. Recombinant proteins 
were purified from E.coli as described in 
section 2.2.4.13, subjected to SDS-PAGE 
and stained with Coomassie blue. 
Purifications were done using Ni-NTA 
affinity purification followed by size 
exclusion chromatography. Lane 1: protein 
marker, lane 2: SUMO1, lane 3: SUMO3, 
lane 4: SUMO 5, lane 5: SUMO6, lane 6: 
SUMO7, lane 7: SUMO7v 
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3.1.3  Cloning of SUMO-activating enzyme  
 
Arabidopsis SAE is a heterodimer consisting of one smaller SAE subunit, SAE1a or SAE1b, and 
the larger subunit of SAE, SAE2. The smaller SAE subunit genes were fragments obtained from 
gateway clone pDEST-SAE1a\b (obtained from Dr. Yong-Fu Fu) digested with NheI and SgrAI 
and inserted into low copy vector pACYC177.  For insertion into pACYC177, the vector was 
first cleaved with ScaI and BanI and re-ligated to destroy the Amp resistance marker before 
cleaving with NheI and SgrAI. The larger subunit SAE2 fragment in pDEST-17 vector was also 
obtained from Dr. Yong-Fu Fu. Both vectors for SAE1a and SAE2 expression were co-
transformed into E. coli for the expression and subsequent purification of SAE. 
 
3.1.4  Purification of Arabidopsis recombinant SAE from E. coli 
 
Arabidopsis SUMO-activating enzyme was purified from E. coli using the Ni-NTA matrix and 
the eluted fractions were further purified by size exclusion chromatography. Fig. 16 shows the 
cell lysates from IPTG-induced and non-induced cultures. The red arrows mark the large and the 
small subunit of the protein in the eluted fraction. 
       
  A.                                                                         B. 
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Fig. 16 Fractionation of the purified Arabidopsis SUMO-activating enzyme by SDS-
PAGE (A) The protein was purified using metal (Ni-NTA) affinity chromatography Lane 1: 
stained marker, lane 2: cell lysate of non induced SAE expressing culture, lane 3: cell lysate of 
IPTG-induced culture, lanes 4 and 5: eluted fractions from Ni-NTA column. The red arrows 
indicate the large and small subunit of SAE after purification in the Coomassie stained gel. (B) 
Purified fractions after size exclusion chromatography of the His6 affinity fraction of 
Arabidopsis SUMO activating enzyme. Lanes 1, 2 and 3 show the various fractions of the 
eluted protein. The large and small subunit of the protein have been marked with red arrows.
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3.1.5  Cloning and expression of Arabidopsis SUMO-conjugating enzyme in pET-9d 
 
The SCE insert was generated from the pSK-SCE (pBluescript-SCE) by cleavage with 
SmaI at RT and followed by NcoI at 37oC. The fragment was excised and purified from 
the gel. pET-9d plasmid vector was cleaved with BamHI, followed by Klenow fill in and 
a final restriction digest with NcoI. The SCE insert was ligated into the linearized 
expression vector and the recombinant DNA (pET-9d SCE) was transformed in E. coli 
(XL1- Blue). DNA was isolated from the transformed cells by the alkaline lysis method 
and screened for the SCE insert by restriction digests. DNA from positive clones was 
transformed in BL 21 cells for further expression studies.  
Some pET-9d SCE expression clones in BL21 cells were tested for the expression of the 
protein by induction with IPTG. The expected size of the protein was about 19 kDa. 
Using precast 4-12% bis-tris gradient gels, the protein migrated slowly and the band 
appeared at around 26 kDa. However, on a self-made Tris buffer 12 % polyacryamide gel, 
the band migrated to a position corresponding to 19 kDa.  
 
3.1.6  Purification of the Arabidopsis SCE from E. coli 
 
The Arabidopsis SUMO conjugating enzyme was purified form 2L of pET-9d SCE 
culture as described in the Material and method section 2.2.4.15. The protein leaks out 
into the supernatant upon freezing and thawing of the cells. The lysate was subjected to 
ion exchange chromatography (SP-Sepharose beads) and further purified by FPLC using 
a Superdex 200 column. The protein eluted in several fractions which were tested by 
SDS-PAGE and the gel stained with Coomasssie stain to visualize the bands. Fig. 17 
shows the SDS-PAGE analysis of the purified Arabidopsis SUMO-conjugating enzyme.  
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3.2       In vitro analysis of sumoylation  
 
3.2.1 Activation of Arabidopsis SUMOs with human sumoylation enzymes 
 
The ability of various Arabidopsis SUMOs to form thioester with human SCE was 
characterized in vitro in presence of MgATP and recombinant human SAE. The products 
of the in vitro reaction were analyzed by SDS-PAGE under non-reducing conditions. A 
range of higher molecular weight bands were visualized on a Western blot with anti-HA 
antibody (SUMOs carry an HA tag). The higher molecular weight bands possibly 
represent thioester to SCE, SAE and isopeptide bonds of the Arabidopsis SUMOs. 
Interestingly, SUMO7 which is not a highly expressed protein in plants was also found to 
be activated by the human sumoylation enzymes in vitro. In addition, thioester bond was  
Fig. 17 Purification of Arabidopsis SCE. The protein was purified using ion exchange 
chromatography followed by further purification with a sizing chromatography column. 
The picture shows a Coomassie stained gel of the purified Arabidopsis SCE fractions after size 
exclusion chromatography. Lane 1: Protein marker, lanes 2, 3, 4 and 5 are fractions of the eluted 
protein from Superdex 200 (size exclusion) column. 
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also formed between SUMO1 (Q93A) mutant and human SCE (Fig. 18), which validate 
our results in vivo (discussed in section 3.4.5) where we were  able to detect conjugates in 
plants expressing the SUMO (Q93A) mutant protein. 
 
 
 
                                  
 
 
 
 
 
 
 
 
 
 
                              
 
3.2.2  Sumoylation of  nucleosome assembly factor (NAF) 
 
Our attempts to enriched and identify SUMO targets in planta (discussed in section 
3.4.6) revealed nucleosome assembly factor (NAF), a factor, involved in the 
biogenesis of nucleosomes, as a potential SUMO substrate in vivo. Inspection of the 
sequence of Arabidopsis NAF revealed the presence of a consensus sumoylation 
site. To test whether sumoylation of NAF occurs in vitro, we used an in vitro assay 
in which purified recombinant NAF (FLAG-NAF) was incubated in the presence of 
recombinant human SUMO-activating enzyme (SAE), SUMO-conjugating enzyme 
(SCE) and bacterially expressed and purified Arabidopsis SUMO1. SDS-PAGE 
analysis and subsequent immunoblotting with anti-FLAG antibody of the in vitro  
 1       2     3      4     5    6     7     8      9 
Fig. 18 Arabidopsis SUMO isoforms and SUMO1 (Q94A) mutant are 
activated by human sumoylation enzymes. Assay for thioester formation 
between SUMO and human SCE. Lane 1: marker, lane 2: SUMO1, lane3: 
SUMO1, human SAE, human SCE, lane 4: SUMO3, lane 5: SUMO3, human 
SAE, human SCE, lane 6: SUMO7, lane7: SUMO7, human SAE, human 
SCE, lane 8: SUMO1 (Q93A), Lane 9: SUMO1 (Q93A), human SAE, 
human SCE. The thioester adducts and potential isopeptide bound forms with 
SAE and SCE proteins and SUMO itself can be visualized as higher 
molecular weight bands with anti-HA antibody on a Western blot. 
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sumoylated products, revealed three slower migrating bands of sumoylated NAF 
(Fig. 19, marked with red arrow). These higher molecular weight bands were absent 
when the enzymes of the sumoylation pathway or the substrate itself were not 
included in the reaction mixture. Several bands detected at a lower molecular 
weight than the NAF which probably represent the various degraded forms of the 
protein.  
   
                                                                  +       -       +       + 
                                                                     -       +      +        + 
                                                                                 -        +       +        + 
                                                                                 -        +       +         -              
                                                                       
                                                      
 
 
 
 
 
 
Since, SUMO1 was found to target NAF in vitro, we also tested the ability of the                     
SUMO1 (Q93A) mutant to conjugate NAF under the same in vitro reaction 
conditions. Western blot analysis with anti-FLAG antibody of the reaction products 
again showed the presence of slower migrating bands, indicating that the mutant 
SUMO (Q93A) was equally active in conjugating NAF as the wild type SUMO.  In 
contrast, SUMO3 and SUMO7, which were also shown to form thioester bonds and 
100
72
54
kDa
NAF 
SUMO1-NAF 
Fig. 19 Sumoylation of NAF in vitro. Purified NAF was incubated in a 
sumoylation buffer in presence of human E1 and E2 and recombinant 
Arabidopsis SUMO1. Reactions were separated by SDS-PAGE, and Western 
blotting was performed using anti-FLAG antibody. Reactions where NAF or 
SUMO1 were not included in the sumoylation buffer, or where all the 
components of the SUMO conjugation pathway were absent, served as 
negative controls. The red arrows mark the position of sumoylated NAF. 
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possibly SUMO-SUMO isopeptide bonds with human SCE, were not able to 
sumoylate NAF in vitro (Fig. 20). Anti-FLAG antibody could not detect any higher 
molecular weight band of sumoylated NAF with SUMO3\7, indicating that these 
proteins may have a different conjugation dynamics or may not modify NAF. 
Whether NAF is a SUMO1 specific target remains to be determined in a 
homologous in vitro conjugation system, and by in vivo studies. 
        
 
                                         
                                            
 
                                           
 
 
 
 
 
 
 
 
 
      3.3       SUMO-conjugating enzyme SCE (C94S) mutant 
 
3.3.1 Phenotypic characterization of plants overexpressing  SCE (C94S) 
 
In collaboration with a research group from McGill University, Montreal, we 
received some Arabidopsis transgenic seeds. The transgenic material consisted of 
lines overexpressing the normal wild type SUMO-conjugating enzyme (SCE)  and the 
lines in which the SCE has been inactivated (SCEIA) due to a mutational change in 
the active site cysteine at position 94 to serine: 
 
      35S: SCEWT > wild type SCE 
      35S: SCEIA > inactive SCE (C94S) 
   1        2      3      4      5      6     7     8      9     10 
Fig. 20 Sumoylation of NAF in vitro by SUMO isoforms. Lane 1:  prestained 
protein marker, lane 2: NAF, lane 3: NAF, SUMO1 (WT), human SAE, human 
SCE, lane 4: SUMO1 (WT), human SAE, human SCE, lane 5: NAF, SUMO1
(Q93A), human SAE, human SCE, lane 6: SUMO1 (Q93A), human SAE, human 
SCE, lane 7: NAF, SUMO3, human SAE, human SCE, lane 8: SUMO3, human 
SAE, human SCE, lane 9: NAF, SUMO7, human SAE, human SCE, lane 10: 
SUMO7, human SAE, human SCE. Western blot was probed with anti-FLAG 
antibody. 
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Phenotypic characterization of SCE mutant was done under long and short day light 
conditions. The growth characteristics of SCE mutant was compared to the plants 
overexpressing the wild type SCE. Two homozygous lines from each of the wild type 
and mutant SCE overexpressing lines were used for this study. Seeds from the 
selected homozygous lines, both of the overexpressing SCE mutant and the wild type 
SCE were stratified on moist filter paper in the dark at 4°C for 3-5 days to break seed 
dormancy and then transferred to soil.  
i) Phenotypic characterization of these mutant lines on soil, showed stunted 
morphology as compared to the wild type (Fig. 21) 
ii) Growth under short day and long day conditions revealed that these plants flower 
early both under long day and short day light conditions in contrast to the wild type 
counterparts (Fig.  22). However, the flowering phenotype of the SCE (C94S) mutant 
was more pronounced under short day growth conditions.  
 
     
 
 
 
 
SCE1 (C94S) 
overexpressed
WT SCE SCE(C94S)
Fig. 21 Photograph illustrating the phenotype of the SCE (C94S) mutant.
Plants overexpressing SCE1 (C94S) do not grow as well as wild type plants. 
Picture on the left is the plant overexpressing the wild type SCE. The plant 
overexpressing the mutant SCE (C94S) on the right shows poor growth.
 
 
Results 
 65
 
 
 
A. 
 
 
 
 
 
 
 
 
 
                
 
 
 
 
 
 
B. 
                      
 
 
       
Fig. 22 Phenotypic characterization of SCE (C94S) mutant under different light 
conditions. Plants overexpressing the mutant SCE flower earlier than the plants 
expressing the wild type SCE both under (A) short day light conditions (8hrs) (B) long 
day light conditions (16 hrs). 
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3.3.2  Characterization of the flowering time of plants overexpressing SCE (C94S) 
 
At least 8 plants from each of the wild type and mutant SCE overexpressing lines were 
used to measure flowering time. The number of rosette and cauline leaves were counted 
before the first flower opened and expressed as a mean ± s.d (standard deviation). Fig. 23 
shows the statistical data in a graphic representation of the early flowering phenotype of 
the SCE (C94S) mutant.  
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3.3.3  Analysis of the SCE (C94S) lines by immunoblot assays 
 
Total protein was isolated from the leaves of wild type and mutant SCE lines. The protein 
mixture was separated by SDS-PAGE (12% gel). Western blotting was performed using 
anti-SUMO1 antibodies to probe crude leaf extract from these lines. A difference in the 
assortment of SUMO conjugates was evident. Some SUMO conjugates (Fig. 24, bands  
Fig. 23 Histogram comparing the number of rosette and cauline leaves 
in the wild type SCE and SCE (C94S) mutant lines. Plants were grown 
under short day light conditions. 
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marked with red arrow) present in the mutant lines were absent in the wild type.  
Moreover, depletion in the level of free SUMO was observed in the mutant lines 
(encircled red in Fig. 24). These observations lead to an hypothesis that the expression of 
inactive SCE (mutant) seems to trap SUMO in one or two predominant dead end products, 
e.g. the conjugate of SUMO to SCE (C94S). Thus, we developed antibodies against 
SUMO-conjugating enzyme (SCE) in order to test the validity of this hypothesis. 
   
                                                          Overexpressed SCE 
                                     Marker   WT               SCE (C94S) mutant 
 
                               
 
 
Fig. 24 Immunoblot assay with protein extracts from SCE overexpressing lines 
using anti-SUMO1 antibody. Some SUMO conjugates (bands marked with red arrow) 
present in the mutant lines were absent from the wild type. Moreover, depletion in the 
level of free SUMO and lower levels of high molecular weight SUMO conjugates was 
observed in the mutant lines 
 
3.3.4   Purification of rabbit polyclonal immunoglobulins (IgGs)  
 
SUMO-conjugating enzyme antibody developed in rabbit (see section 2.2.5) was purified 
from a mixture of crude serum proteins using affinity chromatography technique. The 
serum proteins were first precipitated by ammonium sulphate. The resuspended 
precipitated serum proteins were applied to an affinity column containing a matrix-bound  
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SUMO-conjugating enzyme. The flow through was passed over the column several times 
for proper binding of the IgGs to the affinity matrix. Bound immunoglobulins were eluted  
from the column with 0.2M gylcine HCl (pH 3.0). The eluted fractions were brought to 
higher pH and analyzed by SDS-PAGE. Subsequently, the gel was subjected to 
Coomassie staining. The heavy chain of the IgG was visible in the Coomassie stained gel 
at a size of ~65 kDa and the light chain migrated at ~ 30 kDa (Fig. 25). 
 
 
 
                             
            
 
 
 
3.3.5  Further characterization of SCE (C94S) mutant 
 
The antibody developed against SCE was used to further probe the SCE transgenic lines. 
            When Immunoblot assays were performed with the same transgenic lines probed with 
anti-SCE antibody, a prominent (marked with red arrow in Fig. 26) band, likely the free 
SUMO-conjugating enzyme corresponding to the same molecular weight as the positive 
control (purified SCE), appeared in the mutant SCE (C94S) line (Fig. 26). Accumulation 
of free SCE in the mutant overexpressing lines ruled out our hypothesis that SUMO was 
being trapped as SUMO-SCE conjugate. Therefore, the SCE (C94S) inhibits conjugation 
probably by non-covalent interactions. 
1 2 3 4 5 6 7
Fig. 25 Purification of SUMO-
conjugating enzyme antibody. 
Ammonium sulphate precipitated 
serum proteins were loaded onto a 
column containing the ligand (SCE)
bound to a matrix. The bound 
immunoglobulins were eluted in 
fractions (lanes 2-7) with a low pH 
buffer. Aliquotes were resolved by 
SDS-PAGE and visualized by 
Coomassie staining. Arrow 1 in the gel 
shows the heavy chain of the purified 
IgG and arrow 2 points to the light 
chain. 
1 
2 
   170 
 126 
 100 
    72 
    54 
     
    46 
 
   
   35 
 
   
  24 
   
 
 
 
  17 
kDa 
 
 
Results 
 69
 
 
 
 
 
 
 
 
 
 
 
Fig. 26 Immunoblot with protein extracts from SCE overexpressing lines using anti-
SCE1 antibody. Free SUMO-conjugating enzyme (marked with red arrow)    
corresponding to the same molecular weight as the positive control (purified SCE) 
accumulated in the mutant SCE (C94S). 
 
 
3.3.6   mRNA expression pattern of selected genes in SCE (C94S) mutant plants 
 
The SCE (C94S) mutant has a pleiotropic phenotype, which strongly indicated an 
interference with other gene regulation pathways. We tested the mRNA level of selected 
marker genes namely FLC (a flowering suppressor), CCR2 (a circadian  regulated gene 
and clock regulator),  RD29A, COR47, DREB (cold stress responsive genes)  in the wild 
type SCE overexpressing lines as well as in  the lines expressing the mutant SCE (C94S). 
The mRNA of gene Ch42 was used as a loading control. Total RNA was extracted from 
the SCE lines, and immobilized on a nylon membrane. DNA of the marker genes was 
used as a radiolabelled probe. The mRNA level of SCE was variable in each of the 
homozygous lines used for the study, which explained the varying pattern of expression 
of the genes under investigation. We did not observe a significant difference in FLC 
mRNA levels compared with control plants. Likewise, the circadian rhythm gene, CCR2 
is expressed similarly in wild type and mutant plants. However, analysis of mRNA levels 
of two stress responsive genes (RD29A, COR47) revealed that their expression levels 
were down-regulated in SCE overexpressing plants compared to the plant where no 
transgene was expressed (Fig. 27).  
C94S mutantWT 
overexpressed SCE
MW 
no transgene Purified protein
    (pos. control)
MW 
SCE1
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Fig. 27 Northern analysis of SCE overexpressing wild type and mutant lines using 
FLC, CCR2, RD29A, COR47, DREB probes. RNA was extracted using 20 day old 
plants from two SCE wild type and three SCE mutant expressing lines. RNA blots were 
hybridized with probes derived from DNA of FLC, CCR2, RD29, COR 47, DREB genes, 
respectively. Endogenous Chlorata 42 mRNA which is ubiquitously expressed was used 
as a loading control and for quantification of the result. OX: overexpression 
FLC
CCR 2
RD 29A
COR 47
DREB
WT 
Chr 42 
Loading control 
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       OX 
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Transgenic lines 
                   
           Ratio of signals of probe genes\chlorata 42 control 
                            
SCE\            
SCE(C94S)       FLC         CCR2        RD29A        COR4         DREB 
  WT 1.74 0.21 61.01 7.35 3.21 0.35 
SCE OX 
T2 line 4 
1.87 0.21 37.61 12.6 4.70 0.46 
SCE OX 
T2 line2 
 2.32 0.21 35.25 9.05 3.25 0.39 
SCE(C94S) OX 
T2 line 5 
7.26 0.19 42.40 2.11 1.44 0.33 
SCE(C94S) OX 
T2 line 6 
2.0 0.21 33.11 11.96 5.05 0.43 
SCE(C94S) OX 
T2 line 3 
2.02 0.21 28.95 5.69 2.05 0.36 
 
 
 
 
 
 
    
    3.4      In vivo analysis of sumoylation 
 
    3.4.1   Expression of SUMO isoforms in Arabidopsis  
 
            mRNA for four of the eight Arabidopsis SUMO genes, SUMO1, SUMO2, SUMO3 and 
SUMO5 (Fig. 3; Table 1) were identified by RT-PCR of the total RNA from Arabidopsis 
plants. We could not detect mRNAs for SUMO4, SUMO6, SUMO7 and SUMO8 in total 
RNA, suggesting that they were either not expressed, expressed at low levels, or expression 
was confined to specific developmental stages of the plant not tested here. 
            Epitope-tagged Arabidopsis SUMO genes namely; SUMO1, SUMO3, SUMO5, SUMO6, 
SUMO7 (for SUMO6 and SUMO7, intron-containing genomic constructs were used) under 
the control of a constitutively expressing vector (pHi) were transformed into Arabidopsis thaliana by 
Agrobacterium mediated floral dip transformation. The tags included Strep-tag, triple 
hemagglutinin tag and octa-histidine tag at the amino terminus of the transgene (Fig. 28).  
Table 5. Quantification of the genes regulated in plants overexpressing wild type 
and mutant SCE. Data indicates that cold stress responsive genes RD29A and 
COR47, are down-regulated in SCE over expressing plants. OX: overexpression 
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The transformants were selected on Arabidopsis germination medium containing 
hygromycin and 15 day old transgenic seedlings were then transferred onto soil for seed 
production. Plants expressing intron containing SUMO6 and SUMO7 constructs had 
normal growth characteristics. Overexpression of SUMO1 also did not result in any 
dramatically altered phenotype of the plant. However, overexpression of SUMO3 and 
SUMO5 was toxic to the plant. Thus, inducible transgenic lines both for SUMO3 and 5 
(estradiol inducible expression) were established. For comparative purpose, SUMO1 
inducible transgenic plants were also generated (Fig. 29). 
  
 
                  
 
 
 
 
 
 
 
                              
 
 
 
 
 
 
3x HA tag   His8 tag Arabidopsis SUM  sequence
SUM 1,3,5,6,7 
Strep tag 
Fig. 28 Schematic representation of various SUMO transgenes with three    affinity 
tags at the amino terminus. The SUMO isoforms were individually transformed into 
Arabidopsis thaliana. 
Fig. 29 Photograph illustrating plants overexpressing tagged SUMO1 transgene
under the control of (A) constitutive promoter and (B) inducible promoter 
(estradiol induction; un-induced state).  Plants constitutively expressing SUMO1
have a smaller size than plants in which the expression of SUMO1 can be induced.   
A. Constitutive  
     SUMO1   
    expression 
B. Inducible 
    SUMO1   
    expression 
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      3.4.2  Sumoylation pattern 
 
   Each of the highly expressing SUMO isoforms i.e SUMO1\2, SUMO3, SUMO5 were 
   analyzed for their conjugates using Western blotting technique. Since expression of 
SUMO3 and 5 resulted in plant death, we established trangenic lines that were under 
the control of estradiol as an inducer. For comparative purpose, estradiol inducible 
lines for SUMO1 were also made. Affinity-tagged SUMO1, 3 and 5 constructs with 
estradiol inducible promoter (pER8) were transformed into Arabidopsis by floral dip 
technique. Transformants were selected on Arabidopsis growth medium containing 
hygromycin and 15 day old transgenic seedlings were then transferred onto soil. 
Seeds were collected from the F1 generation and sown on soil after confirming their 
resistance to the selective agent (hygromycin) on germination medium. These 
transgenic lines were further characterized for the level of expression of the 
respective transgene after induction with estradiol. 10 days after transfer from 
germination medium to soil, the transgenic plants were induced O\N by spraying with 
5µM estradiol (see section 2.2.1.11). Total protein was extracted from each line, and 
the proteins were resolved by SDS-PAGE. The resolved proteins were transferred to a 
nylon membrane and probed with anti-HA antibody. The expression of epitope-
tagged SUMO1, 3 and 5 allowed detection of conjugates with all these SUMO 
isoforms (Fig. 30). We did not observe a striking difference in the pattern of 
conjugates among the three SUMO isoforms. At this point, it is an open question 
whether or not the various isoforms have a different spectrum of substrates. Although 
it is difficult to predict the differences in the conjugates of these SUMO isoforms 
from an immunoblot, we hypothesize that variability in the level of deconjugation 
among the various SUMOs may be a distinct possibility.  
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3.4.3   Spliced junctions of poorly expressed SUMO isoforms 
 
In a recent publication (Kurepa et al. 2003), the sequence of  presumed  intron - exon 
structures for all the Arabidopsis SUMO proteins were depicted based on search for 
animal SUMO homologs in the Arabidopsis protein and DNA databases. Since we had 
cloned and expressed both SUMO6 and SUMO7 in Arabidopsis using genes with 
putative introns, we experimentally analyzed the intron and exon pattern in the respective 
genes and found some misassignments in the published data. Forced expression of the 
intron-containing SUMO7 construct allowed detection of mRNA (Budhiraja R. and 
Bachmair A., unpublished). The cDNA isolated indicated the formation of two spliced 
variants, SUM7 and SUM7v. SUM7v has a three amino acid insertion (Glu - Leu - Gln) 
at the position of the second intron (Fig. 31). Forced expression of SUMO6 confirmed the 
intron - exon structure predicted by computer algorithms. 
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Fig. 30 Conjugation pattern of SUMO1, 3 and 5 to substrates in vivo.  Total protein 
was extracted from 10 day old transgenic plants expressing tagged versions of SUMO1, 3, 
and 5 upon O\N induction with 5µM estradiol. SDS-PAGE resolved proteins were 
transferred to nylon membrane and probed with anti-HA antibody. 
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Fig. 31 Spliced variant of SUMO7 differs by a three amino acid insertion. Amino 
acid alignment of SUMO7 and SUMO7v of Arabidopsis thaliana shows conserved 
residues with yellow background. A cDNA splicing variant of SUMO7, SUMO7v, 
contains the three-amino-acid insertion ELQ at the second intron position. 
 
 
3.4.4   Analysis of C-terminal SUMO variants in Arabidopsis 
 
The glycine - glycine (GG) residues that are known to be required at the carboxyl 
terminus of mature SUMO for its conjugation to the substrates were substituted by the 
amino acid residues alanine - alanine (AA), alanine - glycine (AG), glycine - alanine 
(GA), or by the deletion of the last two amino acids in the sequence context of the 
SUMO1 transgene, respectively (Fig. 32). These individually modified SUMO1 variants 
were expressed in Arabidopsis.  
 
 
 
                                                                                                           Variation at C-terminus  
                                                                                                                                      X     Y 
                                                                                                                                     Ala  Ala (AA) 
                                                                                                                                     Ala  Gly (AG) 
                                                                                                                                     Gly  Gly (GG) 
                                                                                                                                     Gly  Ala (GA) 
                                                                                                                                     (Stop)  -    - 
                                                                                                                                    
 
 
 
 
 
 
 
 
 Arabidopis SUM1 sequence
Last two amino        
acids XY 
 
3x HA tag His6 tag 
    Fig. 32 Diagrammatic representation of SUMO1 transgene with affinity tags at the amino  
    terminus and variation in the amino acids at the carboxyl terminus. Individual SUMO variant 
    constructs were expressed in Arabidopsis thaliana. 
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Western blot analysis with crude extracts of the Arabidopsis lines with various amino 
acid residues at the carboxyl terminus showed an array of SUMO1 conjugates with 
substitutions other than glycine-glycine (GG) (Fig. 33). This finding suggests that the 
terminal di- Gly motif is not essential for SUMO1 conjugation in Arabidopsis which 
indicates an unexpected flexibility of the plant SUMO conjugation system. This finding 
perhaps holds true for all other highly expressing SUMO isoforms as well. 
 
 
 
 
 
 
 
 
 
   
                    
 
 
          
 
 
 
 
 
 
 
3.4.5   Analysis of SUMO variants potentially inhibiting deconjugation 
 
Keeping in mind the information that is available about SUMO and the SUMO protease, 
especially the aspect that the SUMO specific proteases have close contact to the conserved 
SUMO1 
conjugates 
Free SUMO1 
   IDAMLHQTAA 
... IDAMLHQTAG 
... IDAMLHQTGG 
... IDAMLHQS 
   no transgene 
Fig. 33 Immunoblot with anti-HA antibody demonstrates conjugation of SUMO
variants to substrate proteins. Individual constructs of tagged SUMO1 transgene 
with amino acid variations at the carboxyl terminus were expressed in Arabidopsis 
thaliana. 
 
 
Results 
 77
 
glutamine (Q) residue at position 93 of the SUMO protein, this residue was substituted 
with alanine (A), aspartic acid (D), leucine (L) or arginine (R), respectively, and 
expressed in Arabidopsis thaliana. The expression of some of these constructs (via 
constitutive promoter) seemed to be fairly harmless to the plant. However, in some cases 
e.g. the expression of (Q93A) was rather toxic and resulted in poor plant development 
(Fig. 34). Inducible transgenic lines were made with these SUMO variants (estradiol 
inducible).  
 
 
                  
 
 
 
 
 
Analysis of these SUMO variant transgenic lines by Western blot analysis detected 
increased accumulation of certain SUMO conjugates in the (Q93A) variant as compared 
to the wild type (Fig. 35, red arrows) and the other variants namely (Q93D), (Q93R) and 
(Q93L), respectively (data not shown). 
 
 
Fig. 34 Photograph illustrating the phenotype of SUMO (Q93A) mutant.  Expression 
of mutant SUMO (Q93A) results in poor plant development and early senescence 
ultimately leading to plant death. 
SUMO (Q93A) WT 
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3.4.6      Biochemical enrichment of SUMO1 substrates 
 
3.4.6.1   Separation and analyses of enriched extracts 
 
The enrichment of SUMO1 substrates was done using transgenic plants overexpressing 
the SUMO1 gene. Although, we had established transgenic lines with all isoforms of 
SUMO, our efforts were mainly concentrated on enriching proteins targeted by SUMO1. 
Enrichment procedures were based on employing the affinity tags present at the amino 
terminus of the SUMO1 gene (Fig. 36) 
SUMO 
conjugates 
Free SUMO 
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     100    
    
      72 
 
  
      54 
       
      46 
 
     
       35 
   
 
      
       24 
  
       17 
   
    
Fig. 35 Immunoblot with anti-HA antibody shows accumulation of SUMO 
conjugates in the SUMO (Q93A) mutant. Constructs with altered residue at a 
site potentially critical for the action of desumoylation enzymes were expressed in
Arabidopsis thaliana. 
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The transgene depicted in Fig. 36 was expressed both under a constitutive (pHi) and 
inducible promoter (pER8) in Arabidopsis. A constitutively high expressing line (SUMO1) 
of the F1 generation was used for biochemical enrichment of the sumoylated proteins. 
~200g of SUMO1 overexpressing plants were ground in presence of 6M guanidinium 
chloride (denaturing conditions). The crude plant extract was cleared of cell debris by 
centrifugation and filtration. Subsequently, a batch procedure was followed for affinity 
purification, using first the Ni-NTA resin followed by Strep affinity matrix. However, the 
second purification step with Strep affinity was unsuccessful and we could not enrich the 
potentially sumoylated proteins using the Strep Tactin resin. We therefore changed our 
enrichment strategy and employed HA tag as our second affinity purification step after 
enriching with the Ni-NTA matrix (Method 1 in material and methods section). Over the 
time, the constitutive expression of SUMO1 gene was lowered, perhaps due to the 
silencing of the gene. Hence, we used inducible Arabidopsis plants (estradiol induction) 
overexpressing SUMO1 for our further efforts to enrich SUMO conjugates. The enriched 
fraction of the tagged SUMO conjugates after Ni-NTA and anti-HA matrix affinity 
purification was concentrated with a Centricon centrifugal device (Amicon) of 10,000 
kDa molecular cut off to a volume of ~50µl. The samples were resolved by one-
dimensional SDS-PAGE followed by Coomassie staining of the gel (Fig. 37).  
 
 
3x HA tag   His8 tag Arabidopsis SUM1  
sequence 
 
Strep tag 
Fig. 36 Schematic representation of SUMO1 transgene with three affinity tags at 
the amino terminus. Expression of amino-terminally tagged SUMO1 facilitated 
enrichment of conjugates. 
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3.4.6.2 Identification of  sumoylated proteins in enriched fractions by mass spectrometry 
 
One–dimensional gel electrophoresis 
 
 An array of proteins was observed in the Coomassie stained gel of the enriched SUMO1 
conjugates. Distinct bands were cut out from the Coomassie stained gel and the 
remaining smeared portion was excised into equal size gel pieces. The samples were then 
digested with trypsin and prepared for MALDI–TOF\MS or LC\MS\MS analysis (section 
2.2.4.7). Fig. 37 shows the proteins identified in the mass spectrometric analysis. This 
analysis identified some candidate SUMO1 targets marked in Fig. 37. We also recovered 
proteins which were likely contaminants, for example Rubisco peptides were identified in 
high amounts in most of the enrichment experiments. 
 
 
 
 
 
 
 
170 
126 
100 
72 
54 
46 
35 
MW 
marker 
MALDI-TOF or
MS/MS data 
Enriched 
extract 
At5g22030 ? (ub-specific protease)
At2g71210 ? (pentatricopeptide repeat protein) 
At5g10230 ? (annexin 7) 
At4g03060 ? (dioxygenase AOP2) 
At2g19480 (nucleosome assembly factor) 
RUBISCO (contaminant) 
At4g35930 ? (unknown function) 
Pectate lyase (contaminant ?) 
SUMO-SUMO conjugate (?) 
Fig. 37 Coomassie staining of the sumoylated proteins enriched from 
Arabidopsis plants overexpressing SUMO1. The sumoylated proteins were 
enriched as described in the text. Red lines point to the identified proteins listed on 
the right. 
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To rule out the possibility of recovering and enriching contaminants, we performed the 
same enrichment procedure with wild type Arabidopsis plants expressing no transgene as 
control. The enriched proteins from both the SUMO1 overexpressing and control plants 
were resolved by a one-dimensional SDS-PAGE (Fig. 38). Corresponding distinct 
Coommasie stained bands from each of the sample lanes (wild type and SUMO1 
enrichment) were excised from the gel and the remaining gel was cut into equal sized 
1mm cubes. The proteins were subjected to in-gel digestion and analyzed by LC\MS\MS. 
Whereas, matrix-assisted laser desorption ionization time-of-flight (MALDI-TOF) mass 
spectrometry technique measures mass-to-charge ratio yielding the molecular weight of 
the peptides, liquid chromatography-mass spectrometry (LC\MS\MS) technique yields 
the masses and fragmentation pattern of peptides derived from proteins. 
LC\MS\MS analysis identified proteins in the control sample that also appeared at the 
same molecular weight in the SUMO1 enriched fractions. This approach clearly 
highlighted the contaminants and helped to focus our search and identification on the 
truly SUMO1 modified proteins. Potential SUMO1 targets were identified from the 
enriched fractions from plants overexpressing the SUMO1 protein (Table 6 and Fig. 38). 
Because the covalent attachment of SUMO (15-20 kDa) to a substrate protein is expected 
to add to its apparent molecular mass by at least 15 kDa, comparison of the observed 
molecular weight of a candidate SUMO substrate to its theoretical molecular weight 
provides an immediate indication of whether it is a likely sumoylated substrate. In ideal 
cases, a SUMO peptide mass should be identifiable among the masses of the identified 
peptides. Based on this criterion, all these proteins were candidate sumoylation targets. In 
addition, these specific proteins were not detected in the wild type control enrichment.  
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Two-dimensional gel electrophoresis 
 
To further analyze and identify enriched SUMO1 targets, we performed two-dimensional 
gel electrophoresis with precipitated samples of the enriched fractions. The precipitated 
protein mixture pellet was resuspended in sample rehydration buffer and isoelectric 
focusing was performed. Proteins were then resolved by two-dimensional electrophoresis 
and stained with Sypro-Ruby stain (Fig. 39, sections 2.2.4.9 and 2.2.4.6). Spots marked 
1-168 in panel (A) of Fig. 39 and spots 1-22 in panel (B) were automatically picked, in-
gel trypsin digests were done with a robot and analyzed by MALDI-TOF. Almost all 
spots in the wild type (Fig. 39B) were identified as Rubisco enzyme. Likewise, in the 
SUMO1 enrichment (Fig. 39A), most of the gel was masked by Rubisco as a 
contaminating protein. The spots which were identified other than Rubisco were not 
suitably fitting the criteria chosen for proteins to be labeled as SUMO1 target. 
170 
126 
100 
72 
54 
46 
35 
LC/MS/MS data
contaminating
proteins 
candidate proteins 
 rib. protein L8  
      catalase  
    phospho-  
      lipase D  
    RUBISCO  
PRL1 int. fact. L
At1g80480  
HPRGP 
    At2g39050  
 stress protein  
At4g27320  
LC/MS/MS data 
   KIP domain protein  
At1g64330   
  RRM domain protein  
At3g56860   
   La domain protein  
At2g43970   
nucleosome assembly 
factor At2g19480  
Fig. 38 Coomassie staining of enriched proteins from SUMO1 overexpressing 
plants and non transgenic wild type as control. Proteins listed on the left are 
sumoylated candidates. The listing on the right in red represents contaminating 
proteins.    
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Candidate 
gene putative function MW 
MW in 
gel score 
analysis 
method ΨKxE/D 
F5O11.15 
kinesin-like 
protein 98.7 ca. 130 29 
MALDI-
TOF no 
       
At5g22030 
ubiquitin-specific 
protease 102.6 ca. 130 27 
MALDI-
TOF yes 
 (UBP8)      
At2g20010 unknown function 107.2 ca. 130 26 
MALDI-
TOF no 
       
At1g71210 
pentatricopeptide 
repeat protein ca. 100 ca. 130 39/25 
MALDI-
TOF no 
       
At5g23080 
has RNA binding 
domains 101,6 ca. 130 29 
MALDI-
TOF yes 
       
At5g10230 annexin 7 ca. 36 ca. 72 30 
MALDI-
TOF yes 
       
 
At1g33900 
avirlulence-
induced (AIG1) 36.8 ca. 72 30 
MALDI-
TOF yes 
       
At3g56720 unknown function 44.3 ca. 72 29 
MALDI-
TOF no 
       
At5g63640 vesicular traffic ? 49.5 ca. 72 24 
MALDI-
TOF yes 
       
At4g03060 
2-oxoglutarate 
dependent  ca. 48 ca. 70 43 
MALDI-
TOF no 
 
dioxygenase 
(AOP2)       
       
At2g19480 
nucleosome 
assembly factor 43.7 ca. 62 183 MS/MS yes  
       
F28O16.5 
 
Oxophytadienoate 
reductase 41.2 ca. 62 33 
MALDI-
TOF no 
 
(OPR1 
      
    At1g11580 
pectin methyl 
esterase 
 39.4 ca. 62 25 
MALDI-
TOF no 
       
At1g27000 
bZIP transcription 
factor 33 ca. 62 24 
MALDI-
TOF yes 
 
 
     At4g35930 unknown function 33.7 ca. 50 37 MALDITOF  Yes 
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Candidate 
gene putative function MW 
MW in 
gel score 
analysis 
method ΨKxE/D 
       
 
 
At1g64330 
Kinase interaction 
domain 1 64,6 ca. 75 108 LC/MS/MS yes 
 
(KIP 1 domain) 
protein      
       
       
At2g43970 La domain protein 60 ca. 72 361 LC/MS/MS no 
 (RNA binding ?)      
       
       
At3g56860 
contains 2 RRM 
domains ca. 50 ca. 70 67 LC/MS/MS no 
 (RNA binding)      
       
       
At2g41060 
contains 2 RRM 
domains ca. 50 ca. 70 67 LC/MS/MS no 
 
(sister gene to 
At3g56860)      
       
At1g27430 
GYF domain 
protein ca. 170 ca. 170 225 LC/MS/MS NA 
 (F17L21.22)      
       
At5g43130 
TATA binding 
protein ca. 90 ca. 110 129 LC/MS/MS NA 
 
associated factor 
4b      
       
At5g06790 
ABC transporter 
homolog 67 73 93 LC/MS/MS NA 
 
PrATH-like 
protein      
       
At3g55760 (F1I16.170) 56 65 83 LC/MS/MS NA 
 
No assigned 
function or domain 
      
At5g08440 (F8L15.170) 60-80 ca. 110 62 LC/MS/MS NA 
 
No assigned 
function or domain 
      
At1g09730 SUMO protease    113  ca. 180 13 LC/MS/MS NA 
 ULP2like2      
 
 
 
       
 
              Table 6. List of potential Arabidopsis SUMO1 substrates  
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Fig. 39 Sypro-Ruby stained two-dimensional gels of enriched sumoylated proteins
using Ni-NTA and anti-HA antibody matrix. Sypro-Ruby staining of the purified proteins 
from (A) plants overexpressing the SUMO1 protein and (B) wild type non transgenic plants. 
168 spots marked in panel A and 22 spots in Panel B were automatically picked, in gel 
digested with a robot and analyzed by mass spectrometry. The spots in green colour were 
identified as protein entities by MALDI-TOF. Spots marked in red colour were not 
identifiable by MALDI-TOF analysis.  
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Another method for enriching SUMO1 conjugates (Method 2 in material and methods 
section 2.2.3) employed using Dyna beads® TALONTM (DYNAL Biotech) which are 
magnetizable beads developed for the isolation of recombinant histidine tagged proteins 
(see Fig.13). The biochemical enrichment using this approach was carried out with plants 
harvested under two different external light parameters for analyzing differences in 
accumulation or the type of SUMO1 targets, under different external environmental 
conditions (absence or presence of light).  SUMO1 overexpressing plants as well as the 
wild type control plants were harvested in dark after 8hrs of dark period and also at noon, 
when the metabolic rate was high. For analytical purpose, enrichment procedure using 
Ni-NTA and Dyna beads was first carried out with  ~ 50 g of plant material harvested in 
dark (after 8 hrs of dark period) and at noon. Aliquots of enriched fractions were 
subjected to one-dimensional gel electrophoresis followed by Sypro-Ruby staining of the 
gel (Fig. 40 A).  
      A.                                                                   B.        
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Fig. 40  (A) Sypro-Ruby stained one-dimensional gel showing SUMO1 conjugates after 
enrichment with Ni-NTA matrix and Dyna beads (B) Western blot of the same with anti -
HA antibody. Plants expressing tagged SUMO 1 transgene and wild type plants were harvested 
in dark, after 8 hrs of dark period and during noon. Lane 1: molecular weight marker, lane 2:
enriched fraction of wild type plants with Ni-NTA matrix (noon), lane 3: enriched fraction of 
SUMO1 expressing plants with Ni-NTA matrix (noon), lane 4: enriched fraction of wild type 
plants with Ni-NTA matrix and Dyna beads (dark), lane 5: enriched fraction of SUMO1 
expressing plants with Ni-NTA matrix and Dyna beads (dark), lane 6: enriched fraction of wild
type plants with Ni-NTA matrix and Dyna beads (noon), lane7: enriched fraction of SUMO1 
expressing plants with Ni-NTA matrix and Dyna beads (noon). 
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Western blotting was done with the same samples using anti-HA antibody (SUMO 
contains a 3x HA tag, Fig. 40 B). Clearly, SUMO1 conjugates were visidualized on the 
Sypro-Ruby stained gel using this method and the level of accumulation of SUMO1 
conjugates was higher in enriched fractions from SUMO1 overexpressing plants that 
were harvested at noon. 
Since plants harvested under light conditions (at noon) showed an increase in the level of 
SUMO1 conjugates, the enrichment using this method (see section 2.2.3, method 2) was 
done with ~250 g of plant material harvested at noon (SUMO1 and wild type). The 
enriched fraction was concentrated with a Centricon centrifugal device (Amicon) of 
10,000 kDa molecular cut off to a volume of ~50µl. The samples were resolved by two- 
dimensional SDS-PAGE followed by Sypro-Ruby staining of the gel (Fig. 41). 
 
A                                                                          B 
                            
 
 
.  
 
 
 
 
 
 
Sypro-Ruby stained spots from the gel were automatically picked; in-gel trypsin digests 
were performed with a robot and subsequently analyzed by MALDI-TOF for 
identification of the peptides. This approach, using a double step purification of enriching  
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Fig. 41  Sypro-Ruby stained two-dimensional gels of enriched sumoylated proteins
using Ni-NTA matrix and Dyna beads. Sypro-Ruby staining of proteins from (A) plants 
overexpressing the SUMO1 protein. (B) Wild type-non transgenic plants. 15 spots marked 
in panel A and 33 spots in Panel B were automatically picked, in-gel digested with a robot 
and analyzed by mass spectrometry.  
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histidine tagged proteins exclusively, was successful in the sense that we were able to get 
rid of Rubisco as a contaminating protein. However, results from the mascot searches did 
not identify any protein to be suitable characterized as a potential SUMO substrate. 
 
3.4.6.3   Identification of sumoylated proteins in enriched fractions using antibodies 
 
We asked whether some SUMO substrates could be identified by methods other than 
mass spectrometry. PROPORZ1 (PRZ1), is a putative Arabidopsis transcriptional adaptor 
protein essential for the developmental switch from cell proliferation to differentiation in 
response to intrinsic factors such as phyhormones (Sieberer et al. 2003). To verify PRZ1 
as sumoylated substrate, we crossed plants overexpressing myc tagged PRZ to plants 
expressing SUMO1 protein. The progeny containing the selected alleles was used for the 
enrichment of PRZ1 by affinity purification. The first purification step involved the use 
of Ni-NTA matrix followed by further enriching the proteins from the Ni-NTA pull down 
with anti-myc antibody bound matrix. Affinity-enriched proteins were separated by SDS-
PAGE. When developed after Western blotting using anti-PRZ1 antibody (Fig. 42), a 
band of 15-20 kDa higher than the actual molecular weight of the PRZ1 protein was 
visualized. A higher size band was observed not only in enriched fractions from plants 
overexpressing the myc tagged PRZ1 and SUMO1, but also from plants expressing 
tagged SUMO1 alone.  
       A.                                                               B.                                           
                                                                           
 
                                
                                            
 
 
kDa                1               2 kDa                 1        3       4 
Fig. 42 Sumoylation of PRZ1 in vivo. Affinity-purified fractions from myc tagged PRZ1 and
SUMO1 overexpressing plants were probed with anti-PRZ1 antibody.  Red arrows show the position 
of the sumoylated PRZ1 protein. Lane 1: crude extract from PRZ1 overexpressing plants, lane 2: 
fraction enriched by Ni-NTA affinity from SUMO1 expressing plants (A), lane 3: Ni-NTA enriched 
from plants overexpressing PRZ1 and SUMO1, lane 4: double enrichment, Ni-NTA followed by anti-
myc antibody bound matrix from plants overexpressing myc-PRZ1 and SUMO (B). 
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Another potential SUMO target tested for enrichment in the purified fractions was 
CONTITUTIVE PHOTOMORPHOGENIC 1 (COP1). COP1 is a regulatory protein that 
suppresses photomorphogeneis in darkness (Deng et al. 1991). PVDF membranes with 
the blotted enriched fractions were sent to Dr. X.W Deng’s laboratory at Yale University 
for probing with COP1 antibody. Western blots with anti-COP1 antibody revealed a band, 
higher by ~10 kDa than COP1 itself in enriched fractions from plants expressing SUMO1 
(Fig. 43). This band was absent in enrichment samples from wild type (non transgenic) 
plants serving as control.  
 
                       Marker    1         2          3      Marker 
                  
  
 
                                                   
Fig. 43 Sumoylation of COP1 in vivo. Enriched 
fractions of SUMO 1 expressing plants and wild 
type as control were tested with COP1 antibody. 
The band marked with red arrow represents the 
sumoylated COP1. End lanes in the picture are the 
molecular weight markers. Lane 1: enriched 
fraction from wild type non transgenic plants and 
lane 2: represents the enriched fraction from 
SUMO1 expressing plants, lane 3: Crude extract 
from wild type non transgenic plants. 
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4. DISCUSSION 
 
4.1   Arabidopsis SUMO proteins 
 
The family of SUMO proteins recently discovered in yeast and animals represents a class 
of polypeptide tags that post-translationally modify and thus regulate numerous 
intracellular proteins in plants. Through searches of the Arabidopsis genome data-bases, 
25 Arabidopsis loci were identified that appear functional as follows: 8 genes encoding 
SUMO, three SAE, one for SCE, at least one potential E3, and a twelve gene family 
encoding putative SUMO proteases (Novatchkova et al. 2004). The similarity of these 
protein sequences to those found in yeast and animals indicates that the SUMO pathway 
has been strongly conserved during eukaryotic evolution. Of the nine Arabidopsis SUMO 
loci, eight (SUMO1-8) are predicted to encode the expected full length proteins of 95-103 
amino acids. By comparison, yeast encodes a single SUMO (Smt3), whereas humans 
encode only four, SUMO1, 2, 3 and 4. By contrast, SUMO9 appears to be a psuedogene. 
Such pseudogenes have been described in other organisms, for example, there are three 
predicted SUMO1 pseudogenes in humans and two in mice (Howe et al. 1998). Like their 
yeast and animal counterparts, the Arabidopsis proteins bear a long N-terminal region 
extending beyond the ubiquitin fold and terminate in a 5-10 amino acid sequence that 
caps the C-terminal glycine essential for attachment. Two proteins (SUMO4, 6) have a 
consensus sumoylation site (ψKXE\D) near their N termini, suggesting that they may be 
involved in forming polymeric SUMO chains (Tatham et al. 2001). Expression studies 
indicate that at least four of the Arabidopsis SUMO genes, SUMO1, 2, 3 and 5, are 
transcribed and highly expressed, implying that a complex assortment of SUMO isoforms 
may exist in each cell type. The expression levels of SUMO4, 6 and 8 are presumably 
much lower. Among the transgenic plants generated, overexpression of SUMO3 and 5 
was toxic and resulted in plant death. Plants with increased levels of SUMO1 conjugates 
showed no gross impairment of general growth (Fig. 29). It is possible that these plants 
display physiological adaptation to higher levels of sumoylation or that the modified 
SUMO1 targets are not involved in any basic growth process. Immunoblot assays with 
antibodies directed against SUMO1\2 (Kurepa et al. 2003, Murtas et al. 2003) and also those 
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directed against SUMO3 indicate that these proteins form conjugates in vivo. Similarly, 
expression of our epitope tagged SUMO3 and SUMO5 allows detection of conjugates 
with these proteins. Thus, all highly expressed SUMO forms in Arabidopsis are involved 
in conjugation reactions. However, an unresolved question is whether various SUMO 
isoforms have different spectra of substrates. Our experiments with NAF as in vitro target of 
Arabidopsis SUMOs showed that NAF is possibly a SUMO1 target and cannot be conjugated to 
Arabidopsis SUMO3 and SUMO7 in vitro (Fig. 20). Further investigation and empirical data 
would be necessary to assess whether or not the various isoforms have diverse spectra of 
substrates.  
 
4.2   C-terminal SUMO variants expressed in Arabidopsis thaliana 
 
Like ubiquitin, SUMO proteins are expressed as precursors that need to be proteolytically 
processed by proteases to make the C-terminal Gly Gly motif available for conjugation. 
This cleavage generates the mature form of the protein and occurs after a conserved Gly 
residue. Most plant SUMO proteins terminate in the same Gly Gly motif at the cleavage 
site as present in animal and fungal SUMOs, whereas the carboxyl termini of  three 
SUMO proteins (SUMO4, 6 and 7) deviate at the penultimate position. SUMO7 has Ala- 
Gly, SUMO4 and SUMO6 have Ser-Gly instead. Interestingly, SUMO1 fusion proteins 
with Ala-Gly or Gly-Ala at this position cannot be processed by SUMO-specific protease 
ESD4 (Murtas et al. 2003). However, when expressed in Arabidopsis, mature SUMO1 
carrying a Ala Gly at this position is still conjugated to substrates (Figs. 32, 33). This 
indicates that the changes present in SUMO4, 6 and 7 do not necessarily compromise 
functionality, although critical parameters of sumoylation and desumoylation may differ 
from the Gly Gly terminal SUMO isoforms.   
 
4.3   SUMO variants potentially inhibiting deconjugation 
 
Sumoylation is a dynamic modification controlled by the balance between the activities 
of SUMO conjugation and SUMO deconjugation machinery. SUMO cleaving enzymes 
that bring about the desumoylation of existing enzymes are a source of free SUMO and 
critical for maintaining normal levels of SUMO conjugations because cellular pools of conjugated 
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SUMOs are presumably very low. From what is known about SUMO and SUMO specific 
proteases, especially that the SUMO deconjugation enzymes have a close proximity to 
the glutamine residue at position 93 in the SUMO gene, we examined the role of SUMO 
proteases in plants by generating mutants with possible defect in deconjugation. 
Substitution of glutamine at position 93 in the SUMO1 gene with aspartic acid, arginine 
and leucine (SUMO1-Q93D, Q93R, Q93L) and subsequent expression in Arabidopsis 
was harmless to the plants. However, SUMO1 (Q93A) expression was toxic and resulted 
in poor growth of the plant with necrotic leaves (Fig. 34). Total protein extracts from 
inducible plant lines expressing SUMO1 (Q93A) immunoblotted with anti-HA antibody, 
showed an increase in the population of sumoylated proteins as compared to the 
unmodified SUMO1 (Fig. 35). Therefore, we reasoned that some SUMO proteases may 
be less efficient in binding the substituted residue at position 93 in the SUMO protein, 
which would lead to the inhibition of deconjugation and hence accumulation of the 
SUMO conjugates.  
 
4.4   Biochemical enrichment of sumoylated proteins of Arabidopsis  
 
Numerous SUMO substrates have been identified either individually or through 
proteomic efforts in mammals and yeast. Two approaches have largely been used for 
identification of target proteins for SUMO modification. One approach is the detection of 
slow migrating proteins in sodium dodecylsulphate polyacrylamide gels, since 
sumoylation should increase the size of target proteins (Matunis et al. 1996, Mahajan et 
al. 1997, Buschmann et al. 2000). The other approach is the use of the yeast two-hybrid 
screening method for interaction between SUMO1\Ubc9 and target proteins (Boddy et al. 
1996, Shen et al. 1996, Desterrro et al. 1999, Müller et al. 2000). A variety of sumoylated 
proteins have been identified with these approaches. The identities of these substrates 
implicate sumoylation in diverse cellular processes. Intriguingly, many transcription 
factors\cofactors and components of the chromatin remodeling complexes have been 
shown to be sumoylated. In plants however, there is very little information on substrates 
targeted by SUMO. We used an in vivo oriented approach, based on detection of slow  
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migrating proteins in SDS polyacryamide gels to identify plant substrates of the 
sumoylation pathway. To assist in affinity purification of SUMO modified cellular 
proteins, we expressed the Strep-HA-His tagged SUMO1 in Arabidopsis thaliana. A 
biochemical approach was undertaken to enrich SUMO1 targets under denaturing 
conditions using 6M guanidinium chloride and 20mM β-mercpatoethanol in the 
extraction buffer. The strategy of the enrichment procedure has been illustrated in Fig.13. 
Briefly, two methods were applied for the enrichment of SUMO1 targets. With both 
methods, the crude extract of the plants expressing SUMO1 was subjected to batch 
purification using Ni-NTA resin for enriching proteins carrying a His tag. The partially 
purified fraction was either further enriched by anti-HA antibody matrix purification 
(first method) or using Dyna beads (second method). The same enrichment protocol was 
also followed with the wild type plants that expressed no transgene. This approach gave 
us a better insight into the contaminating proteins that were pulled down from the 
purification columns along with the SUMO1 substrate(s). One-dimensional SDS-PAGE 
and subsequent mass spectrometric analysis identified 25 novel potentially sumoylated 
proteins in vivo. Consistent with several recent studies in other eukaryotic systems, the 
majority of SUMO1 substrates identified in our screen are involved in transcription, RNA 
processing and maintenance of genome integrity. However, there are no previous reports 
of any of the identified proteins as being SUMO1 targets in mammalian, yeast or even 
plant systems. Analysis of the sequences of the MS identified peptides showed that one 
half of the identified proteins contain a consensus sumoylation site, although presence or 
absence of the consensus site does not make the protein a likely SUMO target. Except for 
At2g19840 (nucleosome assembly factor), every individual attempt at enriching SUMO1 
substrates and subsequent analysis by MALDI-TOF and LS\MS\MS, identified a new set 
of potential SUMO targets, raising the question of reproducibility of our experiments. 
However, it can be argued that the whole process of SUMO conjugation could be acting 
through a dynamic cycle of sumoylation and desumoylation, rather than by persistent 
attachment of SUMO to the substrate. Likewise, the physiological conditions of the 
plants or exogenous environmental parameters at the time harvest may have a role in 
differential conjugation of SUMO to various substrates. Another reason for identification  
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of different substrates in different experiments can be a limiting amount of material, 
which allows unambiguous identification only for a small percentage of the enriched 
proteins. 
Attempts to resolve the enriched SUMO1 substrate proteins (using the second method of 
biochemical enrichment, section 2.3.3) by two-dimensional gel electrophoresis succeeded 
in clearing Rubisco as a major contaminating protein from our enrichments. However, 
Mascot searches with the mass spectrometry data from this methodology approach did 
not yet give convincible results to label the identified proteins as SUMO targets. In view 
of the fact, that  the use of  Dyna beads as our second methodology approach for 
enriching SUMO1 substrates, accomplished clearing the enriched fractions from major 
contaminating proteins such as Rubisco, this step can possibly be adopted as a very initial 
step for purification from crude extracts. Thereafter, the enriched fractions can be further 
purified employing the Ni-NTA resin or anti-HA antibody matrix. 
 
4.5   Arabidopsis thaliana SCE (C94S) mutant  
 
Analysis of the transgenic plants with defects in SUMO conjugation elucidated important 
links of the sumoylation pathway in growth and development of Arabidopsis. These 
plants showed obvious growth impairment. Interestingly, the SCE (C94S) overexpressing 
plants initiated early flowering as compared to wild type overexpressors. Histone 
deacetylase complexes (HDAC) which are involved in chromatin modification are known 
to act as regulators of flowering in Arabidopsis (Amasino 2004), and HDAC in animals is 
subject to post-translational modification by SUMO (David et al. 2002). One likely 
explanation for the flowering phenotype of SCE (C94S) expressing plants is that the role 
of the SUMO proteins in chromatin structure regulation is necessary for proper flowering 
time.  
Free SUMO pool was depleted in the SCE (C94S) mutants, and less high molecular 
weight conjugates could be observed in Western blots probed with anti-SUMO antibody 
(Fig. 24). One possibility was that the mutant version of AtSCE was trapping the free 
SUMO in a dead end product (SUMO-SCE complexes) and thereby depleting the pools 
of endogenous free SUMO. However, immunoblots with anti-AtSCE antibody apparently  
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ruled out this explanation, as bands corresponding to the molecular weight of purified 
SCE were visualized, indicating the presence of free SCE in the mutant lines. Thus, in 
vivo, conjugation of SUMO was probably inhibited by non covalent interactions.  
RNA gel blot analysis showed that mRNA levels of stress responsive genes RD29A and 
COR47 were down-regulated in the plants overexpressing the mutant SCE (C94S) 
compared with wild type plants, suggesting a specialized role of SUMO during stress 
conditions. Differences in the expression of other genes (FLC and CCR2) were less 
dramatic, probably because the SUMO targets involved in the regulation of these genes 
are not present or not perturbed sufficiently in plants expressing the mutant SCE (C94S). 
 
4.6   In vitro sumoylation assays 
 
In vitro data revealed that Arabidopsis SUMO proteins 1, 3 and 7 can be activated by the 
enzymes (human) of the sumoylation pathway resulting in thioester bond formation 
between SUMO and SAE or SCE, as well as isopeptide bonds between SUMO itself (Fig. 
18). Intriguingly, SUMO7 was also found to be active in vitro in presence of the human 
sumoylation machinery although the protein is expressed at a relatively low level in 
planta. Furthermore, using recombinant human SAE and SCE, we report that NAF, a 
factor involved in assembly of nucleosomes in all eukaryotes, is a potential in vitro 
sumoylation target of SUMO1 in the absence of any SUMO ligase. NAF was identified 
by mass spectrometric analysis as a potential sumoylated target in vivo carrying the 
consensus ψKXE sumoylation site and its being an in vitro sumoylation target confirmed 
the validity of our screen. Relying on SDS-PAGE to resolve potentially sumoylated 
products, we could visualize 3-4 bands for the sumoylated NAF in immunoblots probed 
with anti-FLAG antibody, suggesting that NAF is multi-sumoylated. NAF also undergoes 
modification by sumoylation with SUMO1 (Q93A) deconjugation defective mutant, 
supporting our results in vivo, where SUMO1 (Q93A) mutant was shown to be involved 
in conjugation reactions. Our mass spectrometric methods however could not define the 
sumoylation site(s) in NAF, although ψKXE is apparently not sufficient to ensure 
sumoylation. In vitro assays of sumoylation of NAF by SUMO3 and SUMO7 did not 
reveal any slow migrating bands of sumoylated NAF. Thus, it is likely that NAF is  
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specifically a SUMO1 target in vitro, although its conjugation to other SUMO isoforms 
may depend on conjugation dynamics of the specific isoform.   
 
4.7 Sumoylated substrates identified using antibody targeted approach 
 
Identification of potential sumoylation substrates using antibodies against the putative 
target proteins in enriched fractions is an easy and simple method for screening 
sumoylation proteins. Our studies using this approach with antibodies showed that PRZ1 
and COP1 proteins are potential targets for sumoylation in plants. The increased 
molecular weight of the proteins (ca. by 15-20 kDa) as observed on Western blots probed 
with the antibody specific against the protein under investigation gave a reasonable 
indication for being a SUMO target. Although, such analysis offers a faster alternative for 
tracking sumoylation targets, the availability of specific antibodies against the proteins 
may impose restrictions and hamper such investigations.  
 
4.8   Future perspective 
 
The approach presented in this work is the basis on which further strategy toward investigating 
SUMO conjugation in plants can be designed. Although we have identified some novel potential 
SUMO substrates in planta, investigations of how the sumoylation of these proteins affects the 
biological processes in plants needs to be deciphered. Several features of the SUMO system, 
including the low level of modification, the presence of protease activity in case of native lysates, 
and a number of complex interactions among different enzymes and substrates, combine to make 
functional analysis challenging. In fact, for some proteins that have been reported to be 
sumoylated, it is not clear that there is a function, or even that the protein is really sumoylated 
under endogenous expression levels of SUMO pathway enzymes.   
The most important experiment in studying the function of SUMO conjugation to a particular 
protein is mutational elimination of the SUMO attachment site(s). Overexpresison, dominant 
negative or knockdown experiments involving SUMO pathway enzymes can complement these 
results, but it is imperative that such experiments are performed with both wild type 
substrate and the substrate that cannot be sumoylated to confirm correctness of the results. 
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5.  SUMMARY 
 
Among the systems that modify protein structure, the covalent attachment of small 
ubiquitin like modifier - SUMO protein to its substrates (sumoylation) represents after 
ubiquitylation, the best studied example of post-translational modification by a protein 
modifier. SUMO is a peptide of approximately 100 amino acids that modifies proteins of 
many organisms including yeast, humans and plants. SUMO is covalently linked to other 
proteins via a set of specific enzymes, namely SUMO-activating enzyme (SAE), SUMO-
conjugating enzyme (SCE) and SUMO ligases. These enzymes are homologous to E1 - 
E2 - E3 cascade that operates in ubiquitylation. SUMO is emerging as a versatile 
modifier for a large number of proteins in many different pathways and the consequences 
of this modification seem to be as diverse as its targets. Arabidopsis thaliana has eight 
full-length genes with significant similarity to animal and fungal SUMO proteins. 
Phylogenetic analysis clustered the Arabidopsis SUMO proteins into five subfamilies: 
SUMO1\2, SUMO3, SUMO5, SUMO 4\6 and SUMO 7\8. To identify and characterize 
SUMO substrates in plants, we developed transgenic Arabidopsis thaliana lines 
expressing tagged versions of all the SUMO isoforms. Of all these genes expressed in 
Arabidopsis, four (SUMO1\2, SUMO3 and SUMO5) are highly expressed and form 
conjugates with substrate proteins in vivo. Following expression of the affinity tagged 
SUMO1 and subsequent biochemical enrichment, an array of high molecular weight 
SUMO1 substrates was revealed on a Coomassie stained gel. MALDI-TOF analysis 
identified 25 novel potential sumoylation targets in Arabidopsis, some of which carried 
the consensus sumoylation motif. We were able to demonstrate that one of these 
identified sumoylation substrates (NAF) is an in vitro target for sumoylation. 
All SUMO isoforms are made as inactive precursors. They mature by a carboxyl-terminal 
proteolytic cleavage which yields the mature modifier with exposed carboxyl terminus 
di-glycine motif. In order to test the requirement for these residues in conjugation 
reactions, we substituted the double glycine residues with alanine-glycine, glycine-
alanine and alanine-alanine in a SUMO1 transgene. These individually modified SUMO1 
transgenes were expressed in Arabidopsis. Contrary to the expectation, substrates  
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were visidualized on immunoblotting with all the expressed SUMO variants, which 
demonstrates the extreme flexibility of the plant SUMO conjugation system. Moreover, 
an accumulation of SUMO substrates was evident from immunoblot experiments with 
transgenic Arabidopsis plants expressing a SUMO1 (Q93A) mutant. Furthermore, we 
investigated Arabidopsis plants with decreased capacity to conjugate SUMO to its target 
substrates. These plants expressed a mutated version of SUMO conjugating enzyme 
(AtSCE) in which the active site cysteine residue was changed to serine (C94S). 
Phenotypic characterization of these plants deficient in sumoylation showed stunted 
morphology and early flowering characteristics both under short and long day light 
conditions as compared to the wild type counterparts. Immunoblot analysis revealed that 
these transgenic lines had lower levels of free endogenous SUMO. Generally, the results 
suggest that similar to other eukaryotic organisms, many proteins in plants also undergo 
post-translational modification via sumoylation and this process has functional 
significance for development and cell biology of Arabidopsis thaliana. 
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7. APPENDIX 
 
Abbreviations 
 
 
General abbreviations 
 
APS  ammonium peroxodisulfate 
Amp  ampicillin 
AMP  adenosine monophosphate 
At  Arabidopsis 
ATP  adenosine triphosphate 
BAC  bacterial artificial chromosome 
BCIP  5-bromo-4-chloro-3indolyl-phosphate 
bp  base pair 
BSA  bovine serum albumin 
CDD  conserved domain database 
cDNA  complementary DNA from transcribed RNA 
Ci  Curie 
Chr.  chromosome 
Col  Columbia 
Da  daltons 
DEPC  diethylpyrocarbonate 
DMF  di-methylformamide 
dn  down 
DNA  deoxyribonucleic acid 
DTT  dithiothreitol 
EDTA  ethylenediaminetetraacetic acid 
Fig  figure 
FPLC  fast protein liquid chromatography 
GM  germination medium 
GTE  glucose, tris, EDTA 
HA  haemaglutinin (of influenza virus) 
HEPES           (N-[2-hydroxyethyl]piperazine-N'-[2' ethanesulfonic acid]) 
His  histidine 
IPTG  isopropylthiogalactoside 
Kan  kanamycin 
kb  kilobase 
kDa  kilodaltons 
KOAc  potassium acetate 
LC-MS liquid chromatography-mass spectrometry 
LD  long days 
LSB  Laemmli sample buffer 
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mcs  multiple cloning site 
mRNA  messenger RNA 
MALDI -TOF matrix assisted laser desorption ionisation time of flight 
Mb  megabase 
MOPS  3-(N-mopholino) propanesulfonic acid 
MPIZ  Max-Planck-Institut für Züchtungsforschung 
NA  not available 
NaOAc sodium acetate 
NBT  4-nitro blue tetrazolium chloride 
NCBI  National Center for Biotechnology Information 
NCS  newborn calf serum 
Ni-NTA nitrilo triacetic acid matrix charged with Ni++  
NLS  nuclear localization sequence 
NMR  nuclear magnetic resonance 
OD  optical density 
O\N  overnight 
ORF  open reading frame 
PCI  phenol: chloroform: isopropanol 
PcG  polycomb group 
Rif  rifampicin 
RNA  ribonucleic acid 
Rpm  revolutions per minute 
RT  room temperature 
SAE  SUMO activating enzyme 
SCE  SUMO conjugating enzyme 
SD  short days 
SDS  sodium dodecylsulphate 
SENPs  Sentrin proteases 
Strep  streptavidin 
SUMO  Small ubiquitin-like modifier 
TE  tris, EDTA 
Tris  tris(hydroxymethyl)aminomethane 
Ub  Ubiquitin 
UBL  Ubiquitin-like 
UDP  Ubiquitin domain proteins 
ULPs  Ubiquitin-like protein processing enzymes 
v\v  volume per volume 
WT  wild type 
Ws  Wassilewskija 
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Gene abbreviations 
 
APG 8  Autophagy protein 8 
APG12 Autophagy protein 12 
CCR2  Cold circadian rhythm 
COR47 Cold regulated 47 
CREB  CRE binding protein 
CTBP  C-terminal binding protein 
Daxx   Fas death domain associated proteins 
DREB  DRE (dehydration responsive elements) binding protein 
DSK  Drosulfakinin 
EB1  End binding protein 1 
EB2  End binding protein 2 
ESD4  Early in short days 4 
FLC  Flowering locus C 
GMP  GAP modifying protein 1 
HDAC  Histone deacetylase complex 
MDM2 Mouse double minute 2 
NEDD8 Neural precursor cell expressed developmentally downregulated 8 
PC2  Polycomb2 
PIAS  Protein inhibitor of activated STAT 
PIC  PML interacting protein 
PML  Pro myelocyctic leukemia 
RAD23 Radiation sensitive 23 
RanBP2 Ran binding protein 
RanGAP1 Ran GTPase-activating protein 1 
RD29A Response to dehydration 29A 
RUB1  Related to ubiquitin 1 
SMAD4 Mothers against decapentaplegic (Drosophila) homolog 4 
SMT3  Suppressor of maintenance 3 
SIZ  SAP and Miz 
TEL  Translocation E26 transforming-specific leukaemia protein 
ULP1  Ubiquitin-like protease 1 
ULP2  Ubiquitin-like protease 2 
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Sequence of Arabidopsis SUMO transgenes 
 
 
pSK tag 3 SUMO1 insert (524bps) 
 
 
     1 CTCGAGAATTACTATTTACAATTACCATGGCTTCATGGTCTCATCCACAATTCGAAAAGG                               
    61 GTGCTGAAAATATGGGATCCTACCCATACGATGTTCCTGACTATGCGGGCTATCCCTATG 
   121 ACGTCCCGGACTATGCAGGATCCTATCCATACGACGTTCCAGATTACGCTGGTACTCATC 
   181 ACCATCATCATCACCATCATGCTGGTACCCATATGTCTGCAAACCAGGAGGAAGACAAGA 
   241 AGCCAGGAGACGGAGGAGCTCACATCAATCTCAAAGTCAAGGGACAGGATGGAAACGAGG 
   301 TTTTCTTTAGGATCAAGAGAAGCACTCAGCTCAAGAAGCTGATGAATGCTTACTGTGACC 
   361 GGCAATCTGTGGACATGAACTCCATTGCTTTCTTGTTTGATGGGCGTCGTCTTCGTGCTG 
   421 AGCAAACTCCCGATGAGCTTGACATGGAGGATGGTGATGAGATCGATGCGATGCTCCATC 
   481 AGACTGGTGGCTGATCTAGAGCGGCCGCCACCGCGGTGGAGCTC 
 
 
pSK tag3 SUMO3 insert (522 bps) 
 
 
     1 CTCGAGAATTACTATTTACAATTACCATGGCTTCATGGTCTCATCCACAATTCGAAAAGG 
  61 GTGCTGAAAATATGGGATCCTACCCATACGATGTTCCTGACTATGCGGGCTATCCCTATG 
 121 ACGTCCCGGACTATGCAGGATCCTATCCATACGACGTTCCAGATTACGCTGGTACTCATC 
 181 ACCATCATCATCACCATCATGCTGGTACCATGTCTAACCCTCAAGATGACAAGCCCATCG 
 241 ACCAAGAACAAGAAGCTCATGTCATTCTCAAGGTCAAGAGCCAGGATGGAGACGAAGTCT 
 301 TATTTAAGAACAAAAAAAGCGCTCCACTTAAAAAGCTCATGTATGTTTACTGCGACCGCC 
 361 GAGGTTTGAAATTAGACGCATTCGCTTTCATTTTTAATGGAGCTCGTATAGGTGGCCTGG 
 421 AGACTCCAGATGAGCTTGATATGGAAGATGGAGATGTGATAGATGCGTGCCGGGCGATGA 
 481 GTGGTGGTTGATTCTAGAGCGGCCGCCACCGCGGTGGAGCTC 
 
 
pSK tag3 SUMO5 insert (552bps) 
 
 
  1 CTCGAGAATTACTATTTACAATTACCATGGCTTCATGGTCTCATCCACAATTCGAAAAGG 
 61 GTGCTGAAAATATGGGATCCTACCCATACGATGTTCCTGACTATGCGGGCTATCCCTATG 
121 ACGTCCCGGACTATGCAGGATCCTATCCATACGACGTTCCAGATTACGCTGGTACTCATC 
181 ACCATCATCATCACCATCATGCTGGTACCATGGTGAGTTCCACAGACACAATCTCTGCTT 
241 CATTTGTATCAAAGAAGTCTCGATCTCCTGAAACATCACCCCATATGAAAGTCACTCTCA 
301 AGGTCAAGAACCAACAGGGAGCAGAGGATTTGTATAAAATTGGAACTCATGCACATCTAA 
361 AGAAACTAATGAGTGCTTACTGTACGAAGAGAAACTTAGATTACAGTTCTGTCCGATTCG 
421 TCTACAATGGTAGAGAAATCAAAGCTCGACAGACTCCTGCTCAGCTGCACATGGAAGAAG 
481 AAGATGAGATCTGTATGGTCATGGAACTTGGTGGTGGCTGATTCTAGAGCGGCCGCCACC 
541 GCGGTGGAGCTC  
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pSK tag3 SUMO6 insert (567bps) 
 
 
  1 CTCGAGAATTACTATTTACAATTACCATGGCTTCATGGTCTCATCCACAATTCGAAAAGG 
 61 GTGCTGAAAATATGGGATCCTACCCATACGATGTTCCTGACTATGCGGGCTATCCCTATG 
121 ACGTCCCGGACTATGCAGGATCCTATCCATACGACGTTCCAGATTACGCTGGTACTCATC 
181 ACCATCATCATCACCATCATGCTGGTACCATGTCAACGAAGAGCAGTAGTATTCATGGAA 
241 GGAATGAAGTGAAGATGGAAGGGGAAAAGCGTAAAGACGTTGAGTCGGAATCAACTCATG 
301 TTACTCTGAATGTGAAGGGTCAAGATGAGGAAGGGGTTAAAGTCTTCCGGGTGAGAAGGA 
361 AGGCTAGGCTTCTTAAATTGATGGAATATTACGCCAAAATGAGAGGCATAGAGTGGAACA 
421 CATTTCGCTTTCTATCTGATGATGGCTCAAGAATTCGAGAGTATCATACAGCTGATGACA 
481 TGGAGCTGAAAGATGGAGATCAAATCGATGCATTGTTGCCTCAAGAAAGTGGTTGATTCT 
541 AGAGCGGCCGCCACCGCGGTGGAGCTC 
 
 
pSK tag3 SUMO7 insert (513bps) 
 
 
  1 CTCGAGAATTACTATTTACAATTACCATGGCTTCATGGTCTCATCCACAATTCGAAAAGG 
 61 GTGCTGAAAATATGGGATCCTACCCATACGATGTTCCTGACTATGCGGGCTATCCCTATG 
121 ACGTCCCGGACTATGCAGGATCCTATCCATACGACGTTCCAGATTACGCTGGTACTCATC 
181 ACCATCATCATCACCATCATGCTGGTACCATGTCGGCAGCTGACAAAAAACCGTTGATTC 
241 CGCCGTCACATATCACCATCAAAATCAAAAGTCAGGATGACATATGTGTGTACTTCCGGA 
301 TTAAGAGGGACGTTGAGCTCCGTACGATGATGCAAGCATATTCCGACAAAGTTGGACAAC 
361 AAATGTCAGCTTTTAGGTTTCACTGCGATGGAATTAGGATCAAACCCAATCAAACTCCCA 
421 ATGAGCTTGATCTTGAAGACGGAGATGAAATCGATGCATTTGTTGACCAAATAGCAGGGT 
481 GATTCTAGAGCGGCCGCCACCGCGGTGGAGCTC 
 
 
 
SUMO6+introns+flanking sequences (660bps) 
 
 
  1 ACGTAATCATGTCTTGAGAACTGAATTATCTGATCCAACCAGTGGAGATAATGTCAACGA 
 61 AGAGCAGTAGTATTCATGGAAGGAATGAAGTGAAGATGGAAGGGGAAAAGCGTAAAGACG 
121 TTGAGTCGGAATCAACTCATGTTACTCTGAATGTGAAGGGTCAAGTAAGATTTGATTGTT 
181 GAAACTATACAATTTCTATATTAGCATGCATGACTTAATATAACATGTGTGGATTTATGT 
241 AGGATGAGGAAGGGGTTAAAGTCTTCCGGGTGAGAAGGAAGGCTAGGCTTCTTAAATTGA 
301 TGGAATATTACGCCAAAATGAGAGGCATAGAGTGGAACACATTTCGCTTTCTATCTGATG 
361 ATGGCTCAAGAATTCGAGAGTATCATACAGCTGATGACGTATGTATTATCATTCAAGCTT 
421 AAAGATTCTTATAATATATAAAGATAAATCATTCATAAATGATCTTTTTTCACTGTGTTT 
481 TCTCAGATGGAGCTGAAAGATGGAGATCAAATCGATGCATTGTTGCCTCAAGAAAGTGGT 
541 TTTGGTCCTTCTACAGTATTTAGAGTTTGAGTGTTTCTGGTGTGAATGTAATGTTGGAAT 
601 TGGTCAAAGTTGAAGTCGTTTTCTGAGTATTTTCGTATCACGTTTAGCTGAATAAGTTAC 
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SUMO7+introns+flanking sequences (720bps) 
 
 
  1 TGTGAAGATGTCGGCAGCTGACAAAAAACCGTTGATTCCGCCGTCACATATCACCATCAA 
 61 AATCAAAAGTCAGGTACTTGTAATAATCTTAATGTTATTATAAGTTAAATTTTTTTCTAA 
121 AAAGACCACTTTCTTGTTATGCTATTGTGAAAACAATAAATTTTCCATACACAAGTATTT 
181 GGAGATTATGCAAAACAGCAAAGAATTCATTGATTCTAAGTGCTAGGTTTCTAGGTTTTT 
241 TTCTGTTGGTTAAATCGTTGACAGAAAAATACATATTTTCTATAAGTGAATACTTTCTAC 
301 AACCTCAAAGATGATAATATTTTTAATTTTAACCAATCTAAAATTAAGCTGAGTTAACAT 
361 GCGTATAGATTAACATGTTAAATTTTTGTAAATATAATAAAATAGGATGACATATGTGTG 
421 TACTTCCGGATTAAGAGGGACGTTGAGCTCCGTACGATGATGCAAGCATATTCCGACAAA 
481 GTTGGACAACAAATGTCAGCTTTTAGGTTTCACTGCGATGGAATTAGGATCAAACCCAAT 
541 CAAACTCCCAATGAGGTATTTATTTATTTTTGTCATAGAAATGTTACATATGAATCATAT 
601 TGAGAAACAAAAGGAATTGCAGCTTGATCTTGAAGACGGAGATGAAATCGATGCATTTGT 
661 TGACCAAATAGCAGGGTTCAGCCATCGCCATTAAGAGTATCTTAACGATATAAAAAGTCA 
 
 
Mature SUMO7 ORF from cDNA (270bps) 
 
 
  1 ATGTCGGCAGCTGACAAAAAACCGTTGATTCCGCCGTCACATATCACCATCAAAATCAAA 
 61 AGTCAGGATGACATATGTGTGTACTTCCGGATTAAGAGGGACGTTGAGCTCCGTACGATG 
121 ATGCAAGCATATTCCGACAAAGTTGGACAACAAATGTCAGCTTTTAGGTTTCACTGCGAT 
181 GGAATTAGGATCAAACCCAATCAAACTCCCAATGAGCTTGATCTTGAAGACGGAGATGAA 
241 ATCGATGCATTTGTTGACCAAATAGCAGGG 
 
 
Mature SUMO7v ORF from cDNA (279bps) 
 
 
  1 ATGTCGGCAGCTGACAAAAAACCGTTGATTCCGCCGTCACATATCACCATCAAAATCAAA 
 61 AGTCAGGATGACATATGTGTGTACTTCCGGATTAAGAGGGACGTTGAGCTCCGTACGATG 
121 ATGCAAGCATATTCCGACAAAGTTGGACAACAAATGTCAGCTTTTAGGTTTCACTGCGAT 
181 GGAATTAGGATCAAACCCAATCAAACTCCCAATGAGGAATTGCAGCTTGATCTTGAAGAC 
241 GGAGATGAAATCGATGCATTTGTTGACCAAATAGCAGGG 
 
 
Mature SUMO6 ORF from cDNA (324bps) 
 
 
  1 ATGTCAACGAAGAGCAGTAGTATTCATGGAAGGAATGAAGTGAAGATGGAAGGGGAAAAG 
 61 CGTAAAGACGTTGAGTCGGAATCAACTCATGTTACTCTGAATGTGAAGGGTCAAGATGAG 
121 GAAGGGGTTAAAGTCTTCCGGGTGAGAAGGAAGGCTAGGCTTCTTAAATTGATGGAATAT 
181 TACGCCAAAATGAGAGGCATAGAGTGGAACACATTTCGCTTTCTATCTGATGATGGCTCA 
241 AGAATTCGAGAGTATCATACAGCTGATGACATGGAGCTGAAAGATGGAGATCAAATCGAT 
301 GCATTGTTGCCTCAAGAAAGTGGT 
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